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WT wild type
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ABSTRACT
The family Picornaviridae consists of many clinically and economically
significant pathogens of humans (polioviruses, hepatitis A virus,
rhinoviruses) and live-stock (foot-and-mouth disease viruses). Studies on
these small, non-enveloped animal viruses have made a great impact on the
development of modern virology. The first steps of picornavirus infection
include binding to cell surface receptor, entry and uncoating of virus. The
uncoating leads to the release of the positive-stranded viral genome, which
can directly act as a messenger RNA in the translation. The viral replication
occurs in the cytoplasm, where newly synthesized viral capsid proteins and
genome are assembled. The progeny virus particles are, in most cases,
released by lysis of the host cell.
This study focuses on host cell interactions of echovirus 1 (EV1), a member
of the enterovirus genus of Picornaviridae. On the cell surface, EV1 binds to
the α2I domain of α2β1 integrin, a collagen receptor. In the first phase of the
thesis, the virus-integrin interactions were investigated by cryo-electron
microscopy remodelling in a collaborative study. The binding site of α2I
domain was defined as the top of the canyon structure in the EV1 capsid. The
results indicated that there were significant differences in the binding
mechanisms of EV1 and collagen to the integrin. Binding of EV1 to the α2I
domain or on the cell surface did not trigger disassembly of viral capsid and
release of the viral RNA. The results gave new insights into picornavirus-
receptor interactions and into integrin-ligand interactions in general.
In the second and the third phases of the study it was found that EV1 is
internalized into host cells via the cell surface caveolae or by an alternative,
unknown pathway. Caveolae-mediated endocytosis is also important for
cellular functions, however, the detailed mechanisms of the pathway are not
yet thoroughly understood. Both entry pathways of EV1 are dependent on the
presence of α2β1 integrin and they guide the virus into intracellular vesicles,
caveosomes. The real-time live microscopy revealed the rapid uptake of
fluorescently labelled EV1 into these structures. Interestingly, the virus
remained in caveosomes prior to the initiation of viral replication. EV1
endocytosis represents a new model for picornavirus entry and for cellular
endocytic events.
Viruses can have dramatic effects on host cell gene expression. In the fourth
phase, such effects during EV1 infection were investigated using cDNA array
analysis. Changes in host cell gene expression included increased synthesis of
immediate early response genes and genes involved, e.g., in stress response
pathways. EV1 caused also a partial shut-off of host cell protein synthesis, a
mechanism to increase the viral replication efficiency. The results implicated
that EV1 infection has multiple effects on the host cell that might be
consequences of both host cell defence and viral replication.
Finnish Summary
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TIIVISTELMÄ (FINNISH SUMMARY)
Virusten on sitouduttava solunpinnan vastaanottajamolekyyliin, reseptoriin,
aloittaakseen lisääntymiskierron isäntäsolussa. Tämän jälkeen virus menee
isäntäsolun sisään esimerkiksi endosytoosin avulla. Näin virus pääsee
määrättyyn solunsisäiseen paikkaan, jossa se lisääntyy tuottaakseen uusia
viruspartikkeleita. Tuotetut viruspartikkelit vapautuvat solusta aloittaakseen
taas infektiokierron uusissa kohdesoluissa.
Echovirus 1 (EV1) on pieni (30 nm) vaipaton pikornavirus, jolla on
positiivijuosteinen RNA-perintöaines. Pikornavirusheimoon kuuluvat myös
sellaiset merkittävät ihmisten ja eläinten taudinaiheuttajat kuten poliovirukset,
rinovirukset, hepatiitti A -virus ja karjan suu- ja sorkkatautivirus. Tässä
väitöskirjatyössä on tarkasteltu EV1:n solukierron eri vaiheita: viruksen
sitoutumista reseptoriin, endosytoosia, sekä virusinfektion vaikutuksia solun
geenien ilmentymiseen.
EV1 sitoutuu solun pinnalla α2β1-integriiniin, joka toimii normaalisti
kollageenireseptorina. Tarkka sitoutumispaikka integriinissä sijoittuu α2-
alayksikön I-domeeniin (α2I). Tämän väitöskirjan ensimmäinen osatyö oli
kansainvälinen yhteistyöhanke, jossa määritettiin sekä EV1-α2I domeenin
välisen vuorovaikutuksen biokemiallisia ominaisuuksia että α2I-domeenin
sitoutumispaikka viruksessa kryo-elektronimikroskopian avulla. Tulosten
perusteella α2I-domeeni sitoutuu kanjoniksi kutsuttuun syvänteeseen viruksen
kapsidissa.
Toisessa ja kolmannessa osatyössä tutkittiin EV1:n tunkeutumista
isäntäsoluun, mm. elävissä soluissa fluoresoivasti leimatun viruksen avulla.
Integriiniin sitoutuneen EV1:n osoitettiin menevän kaveoli -välitteisen
endosytoosin tai tuntemattoman vaihtoehtoisen reitin kautta solun sisäisiin
kaveosomirakenteisiin. Virus pysyi kaveosomeissa ennen RNA-genomin
monistumista solulimassa. Tähän mennessä EV1 on ainoa pikornavirus, jonka
on näytetty käyttävän kaveolireittiä, ja siten työ tarjoaa uuden mallin
pikornaviruksen soluunmenolle ja antaa myös lisätietoa solun
kuljetusmekanismeista.
Virukset muokkaavat usein solun perustoimintoja ja valjastavat solun
proteiineja omaan käyttöönsä. Neljännessä osatyössä tutkittiin EV1:n
lisääntymiskierron vaikutuksia isäntäsolun geenien ilmentymiseen cDNA-
siruteknikkaa (cDNA array) käyttäen. Viruksen lisääntyminen isäntäsolussa
vaikutti eniten isäntäsolun geenien ilmentymisen muutoksiin. Muutoksia
nähtiin esimerkiksi ohjattuun solukuolemaan, solun stressitilanteisiin ja solun
kasvun säätelyyn liittyvien geenien ilmentymisessä. EV1 myös esti osittain
isäntäsolun proteiinivalmistuksen parantaakseen lisääntymistehokkuuttaan.
Havaitut muutokset isäntäsolussa infektion aikana voivat johtua sekä itse
infektiosta että solun omista torjuntamekanismeista.
Review of the Literature
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REVIEW OF THE LITERATURE
1. Introduction to world of picornaviruses
1.1 Short history and classification of viruses
Viruses are small, infectious agents that can multiply within the cells of
humans, animals, plants, and in bacteria. The first evidence of viruses was
obtained in the 1890s by Dimitrie Ivanowski and Martinus Beijerinck. They
reported that a pathogenic agent associated with tobacco mosaic disease of
plants passed through filters that trapped all known bacteria (reviewed in
Lederberg, 2000). During the same decade, Friedrich Loeffler and Paul
Frosch found that the agent causing foot-and-mouth disease in livestock was
also filterable (reviewed in Mahy, 2005). In 1901, Walter Reed and James
Carrol discovered the viral origin for the serious human disease, yellow fever
(Lederberg, 2000). The virological background of poliomyelitis was
established by Landsteiner and Popper in 1908 when they succeeded to
transfer poliomyelitis from human samples to monkeys in a form of filterable
agent (reviewed in Flint et al., 2000). These investigations initiated
identification of a large number of viruses infecting many organisms.
During the last two centuries, the spectrum of circulating viruses has changed
when the hygiene has improved and potent vaccines have been developed.
However, viruses are still causing many millions of deaths every year because
of several reasons. Viruses evolve all the time, new and emerging viral
epidemics take place and increased travelling enables efficient transmission of
viruses from one continent to another (Lee and Henderson, 2001). On the
other hand, some lethal viral diseases have been completely eradicated from
the world, e.g. the smallpox that caused over 300 million cases in the 20th
century (Mahalingam et al., 2004). Polio eradication is under way (Minor,
2002) and the next target will be measles as assigned by the World Health
Organization (de Quadros, 2004). However, influenza virus is still causing
severe epidemics almost every year (Kilbourne, 2004) and human
Review of the Literature
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immunodeficiency virus, HIV, spreads especially in developing countries
(Steinbrook, 2004).
The extensive epidemics have not only affected humans, but they have caused
serious economical damage also to agriculture by targeting both animals and
cultivated plants. Thus, viruses are mostly regarded as uninvited and
opportunistic guests, which struggle with their host in an effort to replicate
and spread their genetic material. On the other hand, the simplicity of viruses
has made them instruments for gene therapy and for studies on immunology
and cellular and molecular biology (Pelkmans and Helenius, 2003). For
example, discovery that propagation of poliovirus is possible in cell culture
significantly encouraged researchers towards cell biological studies of animal
viruses in 1950s and made development of efficient vaccines possible.
Viruses are classified, for example, based on 1) nature of viral nucleic acid
and replication strategy, 2) presence or absence of an envelope and 3) virion
and nucleocapsid morphology (Condit, 2001). The size of viruses varies from
15 to 300 nm. The viral capsid encloses 3 to 300 kilobases long, a circular or
linear DNA or RNA genome that exists in one piece or in a segmented form.
If the nucleic acid is single-stranded, it can be either positive (+) (same sense
as mRNA) or negative-stranded (-) (complementary to mRNA). Viral capsid
is composed of copies of one or more structural proteins and it displays
icosahedral (spherical viruses), helical (rod-shaped viruses) or more complex
symmetry. In addition, some viruses have a lipid envelope, derived from the
cell membrane through which the viral capsid has budded.
1.2 Common properties of picornaviruses
Classification
This thesis concentrates on the cellular interactions of echovirus 1 (EV1), a
member of family Picornaviridae. Picornaviruses are small (30 nm), non-
enveloped animal viruses. They carry a positive-stranded RNA genome that
can directly act as an mRNA when released into a host cell. Picornaviruses
Review of the Literature
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are divided into nine genera: aphtho-, cardio-, entero-, erbo-, hepato-, kobu-,
parecho-, rhino-, and teschoviruses (King, 2000) (Table 1.) Each genus is
further divided into species, which consist of different virus serotypes with
distinct antigenic determinants. Previously, picornaviruses were classified
mainly according to their pathogenesis in laboratory animals (Hyypiä et al.,
1997) but a current classification is based on genetic information of the virus.
Picornaviruses cause a great variety of diseases in humans and other animals,
varying from hepatitis (hepatitis A virus; HAV), poliomyelitis (polioviruses;
PVs) and common cold (human rhinoviruses; HRVs) to foot-and-mouth-
disease of cattle (foot-and-mouth-disease viruses; FMDVs) (Table 1). In
clinical terms, enteroviruses, to which EV1 belongs, are probably the most
significant members of the picornavirus family. Human enteroviruses (HEV)
contain five different species: polioviruses and HEVs A to D. In addition, the
enterovirus genus contains three species of viruses of other animals: bovine
enterovirus, porcine enterovirus A and porcine enterovirus B (King, 2000;
Stanway et al., 2002).
Enteroviruses cause a wide spectrum of illnesses among new-borns, children
and adults, including respiratory infections, poliomyelitis, meningitis,
encephalitis, myocarditis and conjunctivitis. In addition, increasing data
suggest that enteroviruses may have a role in the development of type 1
diabetes (Hyöty and Taylor, 2002). However, the majority of infections are
asymptomatic (Grist et al., 1978). The faecal-oral route is the main way of
enterovirus transmission. Primary replication of enteroviruses takes place in
respiratory and gastrointestinal tissues. Viremia is caused when the viruses
circulate in the blood stream and can reach target organs, such as liver, heart
and central nervous system (Pallansch and Roos, 2001). Polioviruses (PVs),
the best-studied species among enteroviruses, cause poliomyelitis, a serious
disease that has affected humans for thousands of years. Fortunately, highly
efficient vaccines against PVs have been developed and the worldwide effort
to eradicate polio is likely to reach its goal during the next few years. In June
2002, the WHO European region was certified polio-free, as are the regions of
the Americas and the Western Pacific (Minor, 2002).
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Table 1. Classification of picornaviruses & examples of clinical diseases associated
with picornavirus infections (Grist et al., 1978; King, 2000; Stanway et al., 2002).
Genus Species (No of serotypes)  Clinical Diseases
Enterovirus
Poliovirus (3) (PVs)
- Human polioviruses 1-3
Poliomyelitis
Human enterovirus A (12) (HEV-A)
- Human coxsackieviruses A2-A8, A10-A14, A16
- Human enterovirus 71
Meningitis, paralysis,
myocarditis, rash
Human enterovirus B (37) (HEV-B)
- Human coxsackieviruses B1-B6
- Human coxsackievirus A9
- Human echoviruses 1-7, 9, 11-21, 24-27, 29-33
- Human enteroviruses 69, 73
Meningitis, paralysis,
myocarditis,
gastroenteritis
Human enterovirus C (11) (HEV-C)
- Human coxsackieviruses A1, A11, A13, A15,
A17-A22, A24
Respiratory infections,
conjunctivitis
Human enterovirus D (2) (HEV-D)
- Human enteroviruses 68, 70
conjunctivitis
Bovine enterovirus (2)
Porcine enterovirus A (1)
Porcine enterovirus B (2)
Rhinovirus
Human Rhinovirus A (74) (HRVs) Common cold
Human Rhinovirus B (25) Common cold
Cardioviruses
Encephalomyocarditis virus (1) Carditis
Theilovirus (2)
Aphthovirus
Foot-and-mouth disease virus (7) (FMDVs) Foot- and- mouth disease
Equine rhinitis A virus (1)
Hepatoviruses
Hepatitis A virus (1) (HAV) Liver disease
Parechoviruses
Human parechovirus (2) (HPEVs) Respiratory infections,
gastroenteritis
Ljungan virus (2?)
Erbovirus
Equine rhinitis B virus (2)
Kobuvirus
Aichi virus (1) Gastroenteritis
Teschovirus
Porcine teschovirus (10)
All echovirus (enteric cytopathogenic human orphan) serotypes, including
EV1, belong to HEV-B species (King, 2000). Echoviruses were initially
distinguished from coxsackieviruses by their inability to replicate and cause
disease in newborn mice (Pallansch and Roos, 2001). Echovirus infections are
most often subclinical, although the viruses may cause clinical diseases such
as aseptic meningitis, muscle weakness and paralysis, exanthemas,
pericarditis, myocarditis, common cold, uveitis, conjunctivitis, infantile
diarrhoea, and acute febrile respiratory illness (Grist et al., 1978). The
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outbreaks are most common among neonates and infants (Pallansch and Roos,
2001). Recently, a mouse-model expressing the EV1 receptor, α2β1 integrin,
was developed, enabling establishment of a pathogenetic model for EV1
(Hughes et al., 2003). Intracerebral inoculation of new-born transgenic mice
with EV1 led to paralysis, whereas adolescent mice did not display
neuropathology or paralytic disease but developed myocarditis.
Structure
Picornaviral capsid is an icosahedral, spherical particle with a diameter of
about 30 nm (Fig. 1A, B). The atomic structure of EV1 was recently
determined by cryo-crystallography (Filman et al., 1998). The other atomic
structures of picornaviruses that have been elucidated include CAV9 (Hendry
et al., 1999), CAV21 (Xiao et al., 2001), CBV3 (Muckelbauer et al., 1995),
EV11 (Stuart et al., 2002b), FMDV (Acharya et al., 1989), HRV2 (Verdaguer
et al., 2000), HRV14 (Rossmann et al., 1985), PV1 (Hogle et al., 1985) and
PV3 (Filman et al., 1989). The structure of PVs is best characterized among
enteroviruses and shows their common structural properties.
Similarly to other picornaviruses, the capsid of EV1 is composed of 60
heteromeric structural units, protomers (Filman et al., 1998). A protomer
consists of single copies of each of four capsid proteins VP1-VP4 (Fig. 1B).
Five protomers assemble into a pentamer, and twelve pentamers form a viral
capsid. VP1, VP2 and VP3 decorate the outer surface of the capsid while VP4
is buried inside and represents the detached amino-terminal extension of VP2.
Even though the primary structures of VP1-VP3 are different, each of capsid
proteins contains two α-helices and a similar, eight-stranded, anti-parallel β-
barrel core (Hogle et al., 1985) (Fig. 1C). The loops connecting β-strands are
highly diverse, particularly at the top of the β-barrel domain. The loops and
the C-terminus create the surface features, antigenic properties and receptor
recognition characteristics of the virion.
The five-fold axis is formed of β-barrels from five copies of VP1, whereas the
three-fold axis is surrounded by VP2 and VP3 (Hogle et al., 1985) (Fig. 1B).
The plateau of five-fold axis is encircled by a depression. In echoviruses,
related enteroviruses, and in a major group of rhinoviruses these depressions
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are joined to form a canyon, which is the site of receptor attachment for many
picornaviruses (Rossmann et al., 2002) (Fig. 1B). The "canyon hypothesis"
proposed that the receptor binds to the conserved sequences on the bottom of
the canyon and thus escapes the neutralizing host antibodies that are too large
to reach the receptor-binding site (Rossmann, 1994). Later, this hypothesis
was challenged as receptor and antibody binding sites partially overlap on
capsid surface (Rossmann et al., 2002).
Figure 1. Structure of picornaviruses. A) Electron micrograph of negatively stained
EV1 shows small, spherical viral particles. Scale bar 100 nm. B) The picornavirus
(EV1) capsid consists of 60 protomers. VP1, VP2 and VP3 of one protomer are
indicated in the virus capsid. VP4 is buried inside the capsid. Three-fold (3) and five-
fold (5) symmetry axes and the canyon are indicated by arrows. (The model of EV1
capsid was adapted from http://mmtsb.scripps.edu/viper/; copyright © 1998-2004 by
TSRI) C) Capsid proteins VP1, VP2, and VP3 share a common core structure of eight
β-strands, connected by loops (Modified from Hogle, 2002).
The N-terminal residue of VP4 of all studied enteroviruses, including EV1, is
covalently bonded to a myristic acid group (Chow et al., 1987). This fatty
acid may play a role in the capsid assembly and entry events. Moreover, in
most enteroviruses and in a major group of rhinoviruses, the hydrophobic
bottom of the canyon contains a pocket-factor of cellular origin (Filman et al.,
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1989). The pocket factor (=lipid) stabilizes the capsid and it is released before
uncoating (Racaniello, 2001). Thus it may prevent premature uncoating and
RNA release and also ensure that viruses are carried from the cell in an intact
form.
Viral genome
The size of the single-stranded (+)RNA of picornaviruses varies from 7.2
(HRV14) to 8.5 (FMDV) kilobases. The genome contains a single open
reading frame (Fig. 2).
Figure 2. Genomic structure of enteroviruses. The P1 region (white) is processed to
structural proteins VP1-VP4. The P2 and P3 regions (gray) are processed to
nonstructural proteins. The principal functions of viral proteins during infection cycle
are presented in boxes. (Modified from Bedard and Semler, 2004).
The 3' and 5' ends of the viral RNA contain untranslated regions (UTRs). The
3' end of picornaviruses carries a PolyA -sequence (Yogo and Wimmer,
1972), and a secondary structure (pseudoknot), used for initiating the
synthesis of negative strand RNA (Jacobson et al., 1993). The 5' end of the
viral RNA is not capped like cellular mRNAs, but instead it contains a
covalently attached viral protein 3B, also called VPg (Nomoto et al., 1977).
An internal ribosome entry site (IRES), which is required for cap-independent
translation(Pelletier and Sonenberg, 1988), and the clover-leaf structure,
which is involved in RNA replication (Andino et al., 1990), are also present at
the 5' end.
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The enterovirus genome is translated to one polyprotein, which is further
cleaved to precursor proteins P1, P2 and P3. P1 precursor protein is cleaved
into the structural proteins VP1-VP4. The nonstructural proteins, which are
required for proteolytic cleavages, for viral translation and for RNA
replication, are formed from precursors P2 (2A, 2B, and 2C) and P3 (3A, 3B,
3C and 3D) (Racaniello, 2001). The 3D is an RNA-dependent RNA-
polymerase, which specifically copies viral RNA in the presence of VPg
primer (Baltimore et al., 1963; Nomoto et al., 1977). The 2A acts as a
protease in enteroviruses and rhinoviruses and the 3C in all picornaviruses
(Hanecak et al., 1982; Toyoda et al., 1986).
Replication cycle
Attachment (1) and entry (2). Viral infection starts by interaction of virus
with its cell surface receptor or multiple receptors (Fig. 3.). In picornaviruses,
the receptor interactions may result in conformational changes essential for
viral entry and RNA release (=uncoating) (Rossmann et al., 2002). Uncoating
may also be triggered by other factors, such as acidification. The receptor-
triggered uncoating of PVs may be followed by penetration of viral RNA into
the cytoplasm through a pore within the plasma membrane (Hogle, 2002).
Alternatively, picornaviruses can be endocytosed into the host cell prior to the
uncoating. After viral genomic RNA is released into the cytoplasm, the
genomic VPg is cleaved. The (+)RNA acts directly as mRNA for synthesis of
the viral polyprotein precursor.
Translation (3). Since cellular proteins cannot copy picornaviral RNA, it
must first be translated in order to produce viral proteins required for
replication of the viral genome. Picornaviruses inhibit the cellular protein
synthesis by cleaving the cellular components, which are essential for cap-
dependent cellular translation (Etchison et al., 1982; Gradi et al., 1998).
However, the cap-independent translation of viral proteins is allowed due to
the presence of IRES in the enterovirus genome (Dorner et al., 1984; Pelletier
and Sonenberg, 1988). In addition to canonical initiation factors, some
noncanonical factors, such as poly(rC) binding protein, are required for
initiation of viral translation (Racaniello, 2001). The instant cleavage of the
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Figure 3. Life cycle of picornaviruses: 1) Attachment, 2) Entry 3) Translation, 4)
Replication, 5) Assembly and 6) Release. Each number is referred to in the text.
(Modified from Flint et al., 2000).
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translated polyprotein is performed by virus-encoded proteinases (Kitamura et
al., 1981; Semler et al., 1981). The non-structural proteins (except 2A), which
are cleaved from precursors P2 and P3, participate in viral RNA replication.
Replication (4). Picornaviruses, like other RNA viruses, have membrane-
associated replication complexes (Egger et al., 2002). With picornaviruses,
the rosette-like complexes consist of replicating viral RNA, viral and cellular
proteins, and tubulated, virus-induced membranous vesicles. The replication
is initiated by a complex of viral and host cell proteins bound to 5' cloverleaf
of viral RNA (Andino et al., 1999). Viral 3Dpol copies genomic (+)RNA into
complementary (-)RNAs, which carry VPg at their 5' ends and serve as
templates for newly synthesized genomic (+)RNA. Simultaneously, VPg is
removed from some of the newly synthetized (+)RNAs that are further
translated for efficient production of viral proteins.
Assembly (5) and the release (6). A precursor protein P1 is further cleaved
into coat proteins VP0 (a precursor of VP4 and VP2 in most of the
picornaviruses), VP3 and VP1. Protomers, carrying one copy of each coat
protein, associate with genomic RNA containing VPg to form progeny viruses
(Racaniello, 2001). Finally, VP0 is cleaved into VP4 and VP2 for production
of infectious viral particles. Picornaviruses, like most nonenveloped viruses,
are usually released from cells by cell lysis.
The replication cycle of picornaviruses takes approximately 6 to 12 hours in
cells. About 50 000 new viral particles are produced during each cycle in one
cultured cell but only 0.1-2% of them are infectious (Racaniello, 2001). This
may be due to the lethal mutations in the viral genome and/or other defects of
the infectious cycle.
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2. Picornavirus-receptor interactions
2.1 General principles of virus-receptor interactions
In order to enter into host cells and initiate infection, viruses must attach to
the specific receptor(s) on the cell surface. These receptors can often have
important functions in cell adhesion, cell-cell interactions, signalling and
defence mechanisms. The binding of virus to a receptor can elicit changes in
receptor conformation. These alterations may bring about signalling events
that regulate both the viral entry process and the cellular response to the
infection. On the other hand, conformational changes in virus particles,
triggered by receptor binding, can also facilitate virus entry and uncoating.
Among the best characterized virus-receptor interactions are those of HIV
with CD4 molecule and chemokine receptors (reviewed in Smith and
Helenius, 2004). Binding of HIV to CD4 molecule on the cell surface leads to
conformational changes in virus structure. These changes allow the further
interactions of HIV with chemokine receptors that in turn promote the fusion
of viral envelope with the plasma membrane and subsequent release of viral
core into the cytoplasm.
Picornaviruses can interact with a great variety of cell surface molecules,
including members of immunoglobulin superfamily (IgSF) and integrins
(Evans and Almond, 1998)(Table 2 and Fig. 4). Many picornaviruses share
cellular receptors, for instance, decay accelerating factor (DAF) functions as a
receptor for several enteroviruses, and αv-integrins are utilized by FMDVs,
human parechovirus 1 (HPEV1) and coxsackievirus (CAV) 9. Furthermore,
picornaviruses and other viruses can utilize the same receptors; for example,
both CBVs and adenoviruses bind to coxsackievirus-adenovirus receptor,
CAR (Tomko et al., 1997). Often, one receptor is required for binding and
another for uncoating and entry (Rossmann et al., 2002): e.g. CAV21 binds
primarily to DAF but enters the cells via an intercellular adhesion molecule-1
(ICAM-1) (Shafren et al., 1997). Alternative receptor(s) may also be utilized
depending on cell type and cell polarization. For example, CBV3 can infect
the apical surface of polarized epithelium which expresses its secondary
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receptor DAF (Shafren et al., 1995), even though a primary receptor, CAR
(Bergelson et al., 1997; Tomko et al., 1997), is hidden within intercellular
junctions (Shieh and Bergelson, 2002). However, for some picornaviruses,
like PVs (Mendelsohn et al., 1989) and a major group of HRVs (Greve et al.,
1989), one receptor is enough to ensure attachment, uncoating and entry.
Table 2. The examples of cell surface receptors for picornaviruses. (Modified from
Racaniello, 2001).
RECEPTOR(S)  VIRUS
IgSF-like
- Poliovirus receptor; CD155, PVR Polioviruses 1,2,3
- Intercellular adhesion molecule -1; ICAM-1 Coxsackieviruses A13, A18, A21
Major group of rhinoviruses
- Coxsackievirus-adenovirus receptor; CAR Coxsackieviruses B1-B6
- HAV cellular receptor 1; HAVcr-1 Hepatitis A virus
SRC-like
- Decay accelerating factor; CD55; DAF Coxsackievirus A21*
Echoviruses 3, 6, 7, 11-13, 20, 21, 24, 29, 30
Enterovirus 70
Coxsackieviruses B1, B3, B5*
Integrins
− α2β1 integrin Echovirus 1
− αvβ3 and αvβ6 integrin Coxsackievirus A9
− αvβ1 and αvβ3 integrin Parechovirus 1
− αvβ1, αvβ3, αvβ6 and α5β1 integrin Foot-and-mouth disease virus (field isolates)
Signalling receptors
- Low-density lipoprotein receptor; LDL-R Minor group of rhinoviruses
Carbohydrates
- Sialic acid Rhinovirus 87
Enterovirus 70*
Glycosaminoglycans
- Heparan sulphate Foot-and-mouth disease virus (culture
adapted)
Echovirus 6 and certain other serotypes*
Others
− β2 microglobulin (β2m) Certain echovirus serotypes*,
Coxsackievirus A9*
*) the virus uses the receptor as a "secondary" receptor. SRC= short consensus repeat
It is important to keep in mind that the reported virus-receptor interactions are
usually based on cell culture studies of laboratory strains of viruses, which
have adapted to certain receptors and may not be similar to the clinically
circulating viruses. For example, the field isolates of FMDVs bind to integrins
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while laboratory strains of viruses use heparan sulphate as a receptor (Jackson
et al., 1996; Neff et al., 1998).
Figure 4. Different types of picornavirus receptors. SRC=short consensus repeat,
GPI=glycosylphosphatidyl inositol anchor (Modified from Evans and Almond, 1998).
Binding of natural ligands to cell surface molecules is known to induce
conformational changes and, sometimes, clustering of receptors, which may
lead to a variety of signalling events (Greber, 2002). Similarly, virus-receptor
interactions can trigger signalling events that influence virus entry,
cytopathogenecity and the immune response. So far, signal transduction
following the picornavirus-receptor interactions has not been extensively
studied. Interestingly, recent findings suggest that the interactions of EV1
with its receptor, α2β1 integrin, can trigger a cascade of signalling events,
including protein kinase Cα activation (Upla et al., 2004). These signalling
events are required for virus internalization into the host cell (Pietiäinen et al.,
2004; Upla et al., 2004). This is somewhat similar to the signalling events
observed during adenovirus (Ad-2 and Ad-5) interaction with αv-integrins.
The adenovirus-integrin interaction results in an activation of several
signalling pathways and dynamic changes in the actin cytoskeleton, events
which mediate internalization and endocytic trafficking of the virus (Greber,
2002; Goosney and Nemerow, 2003).
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Although virus-receptor interactions are required for initiation of infection
and may promote the subsequent steps of the viral life cycle, the viral
pathogenesis is not determined only by receptor recognition (Schneider-
Schaulies, 2000). In addition, intracellular factors, the velocity of virus
replication, cytopathogenecity, the spread of infection within and between
organs and the host immune response have an influence on the development
of disease.
2.2 Integrins as picornavirus receptors
Structure and function of integrins
Integrins are heterodimers of two covalently associated subunits, α  and
β (Ruoslahti and Pierschbacher, 1987; Takagi and Springer, 2002) (Fig. 5).
Currently, 24 combinations of 18 integrin α and eight integrin β subunits are
known (Hynes, 2002). The subunits contain a large extracellular domain of
≥940 (α) and ≥640 (β) residues, a single transmembrane domain and a short,
C-terminal, cytoplasmic tail (Fig. 5).
Figure 5. The structure of integrin, which contains the I domain in the α subunit.
(Modified from Humphries, 2002; Hynes, 2002).
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About half of vertebrate integrin α subunits contain an I ("inserted") domain
(Whittaker and Hynes, 2002). I domain is a member of a family of von
Willebrand A domains (VWA). The members of the VWA family share a
common structure of Rossman folds, which consist of a β-sheet sandwiched
between multiple α helices (Lee et al., 1995) (Fig. 6). I domain interacts
with the β-propeller, which is formed of seven similar structural units (∼60
amino acids each) (Springer, 1997). The leg the of α-subunit consists of a
thigh domain and two calf domains (Hynes, 2002). The head of all β-subunits
contains an I-like domain, which shares a common structure with αI domains
(Lee et al., 1995) (Fig. 5). The β I-like domain interacts with α-subunit,
forming an interface for a ligand binding. The leg of β-subunit has a hybrid
domain, plexin-semaphorin-integrin (PSI) domain, four cystein-rich repeats
(I-EGF; epidermal growth-factor domains) and a novel cystatin-like fold (β-
tail domain) (Hynes, 2002). A metal-ion binding site (MIDAS), essential for
ligand binding (Michishita et al., 1993), is present in both the αI domain and
β I-like domain.
Integrins are cell-adhesion receptors, crucial for cell invasion, migration and
survival (Hood and Cheresh, 2002). Therefore, they are involved in
developmental processes, immune response, chronic inflammation and
invasion of cancer (Hynes, 2002). Integrins bind many ligands, including a
large number of extracellular matrix proteins (e.g. collagens, fibronectins,
vitronectin, laminins, von Willebrand factor and thrombospondins), counter-
receptors (ICAMs and generally members of the IgSF) and plasma proteins
(Hynes, 1992). Numerous pathogens, including adenoviruses (Wickham et al.,
1993), cytomegaloviruses (Feire et al., 2004), picornaviruses (Bergelson et
al., 1992; Roivainen et al., 1994; Berinstein et al., 1995) and rotaviruses
(Guerrero et al., 2000; Ciarlet et al., 2002) utilise integrins as cell surface
receptors. Many but not all integrin ligands contain an arginine-glycine-
aspartatic acid (RGD) tripeptide that specifically binds to certain integrins,
such as α5β1, αVβ3, αVβ5, αVβ6 and αVβ8 (Ruoslahti and Pierschbacher,
1987).
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Integrin signalling and activation are both mediated by large conformational
changes that are propagated from the integrin headpiece to the cytoplasmic
domains and vice versa (Hynes, 2002). Thus, integrins can signal in both
directions, outside-in and inside-out. Binding to the matrix induces
association of integrins with the actin cytoskeleton and activates biochemical
signals inside the cell. Conversely, intracellular signals can promote the
binding of integrins to matrix ligands. This inside-out signalling may trigger
transformation of integrins from a closed and inactive "low affinity"
conformation to an open and active "high affinity" state (Takagi and Springer,
2002). The high affinity conformation of integrins is required for binding of
some ligands, e.g. collagen (Emsley et al., 2000). The ligated integrins can
cluster by oligomerization of their transmembrane domains, which results in
the activation of cellular signalling cascades (Qin et al., 2004).
αv integrins bind picornaviruses via a viral RGD motif
Picornaviruses CAV9 (Chang et al., 1989), HPEV1 (Hyypiä et al., 1992) and
FMDVs ( Fox  et al., 1989) contain an RGD motif (Ruoslahti and
Pierschbacher, 1987), which often offers a binding site for integrins. The
RGD sequence is present in the capsid protein VP1 on the surface of viruses
(Fox et al., 1989; Chang et al., 1992). In contrast to many other picornavirus
receptors, the integrins interacting with RGD-containing picornaviruses do
not appear to bind into the virus canyon.
CAV9 was first shown to utilize the αvβ3 integrin as a receptor (Roivainen et
al., 1991; Roivainen et al., 1994), but, according to later reports, it can also
bind to other αv-integrins, such as αvβ6 (Williams et al., 2004). The
interaction of CAV9 with αvβ6 is RGD-dependent (Williams et al., 2004).
However, RGD is not essential for CAV9 infectivity, as the virus can
efficiently bypass the RGD-dependent entry (Roivainen et al., 1991; Hughes
et al., 1995; Roivainen et al., 1996). This suggests that CAV9 could also use
other receptors for cell entry. Indeed, MHC class I protein as well as two
MHC class I -associated proteins, β2 microglobulin and GRP78 (a member of
heat shock protein-70 family of stress proteins) may be involved in the entry
process of CAV9 (Triantafilou et al., 1999; Triantafilou et al., 2002).
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HPEV1 was found to compete with CAV9 for the cell surface binding,
therefore leading to the presumption that these viruses may share a common
receptor (Roivainen et al., 1994). Indeed, HPEV1 also utilizes αv-integrins as
receptors (Stanway et al., 1994), e.g. αvβ1 (Pulli et al., 1997) and αvβ3
(Stanway et al., 1994; Joki-Korpela et al., 2001). In contrast to CAV9, the
RGD motif has been shown to be critical for HPEV1 viability (Boonyakiat et
al., 2001). Interestingly, αvβ3 integrin does not only act as an attachment
receptor but it may also direct the virus to the clathrin-mediated
internalization route (Joki-Korpela et al., 2001).
Field isolates of FMDVs can recognize several integrins, including αvβ3
(Berinstein et al., 1995), αvβ6 (Jackson et al., 2000b), αvβ1 (Jackson et al.,
2002), and α5β1 (Jackson et al., 2000a). Binding of FMDVs to integrins is
RGD-specific (Jackson et al., 1997; Jackson et al., 2000b). However, if the
RGD sequence of FMDVs is mutated or if the viruses are grown in cell
cultures (Jackson et al., 1996; Sa-Carvalho et al., 1997), they are able to
switch the receptor to heparan sulphate on the cell surface (Baranowski et al.,
2000).
α2β1 integrin as a receptor for EV1
The interaction of EV1 with α2β1 integrin (Bergelson et al., 1992) is serotype
specific as only EV1 and its homologue EV8 among echoviruses bind to the
integrin (Bergelson et al., 1993b; Ohman et al., 2001). In contrast to CAV9,
HPEV1 and FMDVs, EV1 does not carry an RGD tripeptide. α2β1 integrin
(VLA-2) is expressed in several cell types, including fibroblasts, platelets,
endothelial cells, and epithelial cells from multiple sites, i.e. skin,
gastrointestinal tract, lung and bladder (Zutter and Santoro, 1990). The natural
ligands of α2β1 integrin include collagen (Santoro, 1986), laminin (Elices and
Hemler, 1989) and E-cadherin (Whittard et al., 2002). After cell adhesion to
collagen, α2β1 integrin is known to regulate the mitogen-activated protein
kinase (MAPK) pathways (Heino, 2000). The α2 subunit contains a ligand-
binding I domain (α2I), which carries the C-helix not found in all αI domains
(Takada and Hemler, 1989; Bahou et al., 1994; Emsley et al., 1997) (Fig. 6).
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The murine homologue of α2 integrin subunit does not bind to EV1 even
though it is 84% identical to human α2 subunit (Edelman et al., 1994).
Instead, production of the human α2 subunit in rodent cells is required for
making these cells susceptible to EV1 infection, thus indicating that human
α2/mouse β1 heterodimers can serve as functional EV1 receptors (Bergelson
et al., 1993b; Zhang and Racaniello, 1997). However, when the murine
α2 subunit was replaced by human α2I domain, the murine α2β1 integrin also
supported virus binding (Bergelson et al., 1994b). The finding suggested that
EV1 binds to the α2I domain of α2β1 integrin, like a physiological ligand
collagen (Takada and Hemler, 1989; Bahou et al., 1994; Kamata et al., 1994).
This was further supported by a finding that a bacterial fusion protein of the
α2I domain specifically bound EV1 and prevented virus attachment to the
cells (King et al., 1995).
Figure 6. In the α 2I domain, one short
antiparallel and five parallel β-strands (βA-
βE) form a core β -sheet, which is
surrounded by seven amphipathic α-helices
(Lee et al., 1995; Emsley et al., 1997). The
C-helix extends from a top of strand βE and
creates a groove, where collagen binds
through interactions with the MIDAS. The
residues 199-201, 212-216 and Arg289 have
been reported to interact with EV1 (King et
al., 1997; Dickeson et al., 1999).
Even though both collagen and EV1 bind to the α2I domain, their interactions
with integrin differ in many aspects. In contrast to collagen, the virus binding
to α2β1 integrin does not discriminate between inactive and active
conformation of the integrin (Emsley et al., 2000). Studies with monoclonal
antibodies against α2I domain suggested that binding sites of EV1 and
collagen within the α2I domain are different (Kamata et al., 1994; Kamata
and Takada, 1994). In addition, the MIDAS site, essential for collagen
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binding, is not involved in the interaction of EV1 and the integrin (King et al.,
1997). Thus, EV1-α2β1 integrin interaction is not dependent on any particular
divalent cation (Bergelson et al., 1993a).
The studies with murine and human α2I chimeras identified the EV1 binding
sites in the α2I domain as amino acids 199-201 and 212-216 (King et al.,
1997). These two regions interacted with the virus independently. All these
residues lie on the exposed face of the I domain (Fig. 6). To investigate
further the determinants of ligand binding specificity of α2β1, a collagen-
binding chimera of α2 and α1 I domains was constructed (Dickeson et al.,
1999). However, EV1 could not bind to α1I domain, and binding to α2I
domain was lost in a chimera containing the αC region, the αC-α6 loop, and
the α6 helix of α1. Further mutational analysis of the α1I/α2I domain
chimeras identified amino acid Arg289 in αC-α6 loop of α2I domain to be
critical for virus binding (Dickeson et al., 1999) (Fig. 6).
2.3 Other picornavirus receptors
Picornavirus receptors of Ig superfamily bind to the virus canyon
Several picornaviruses, including PVs, major group HRVs and CBVs use
cell-surface molecules belonging to the immunoglobulin superfamily (IgSF)
as their receptors (Table 2). Picornavirus receptors of IgSF are type I
transmembrane glycoproteins and consist of tandem repeats of two to five Ig-
like domains, a transmembrane domain, and a short cytoplasmic tail (Fig. 4).
The interactions of picornaviruses with IgSF members are usually mediated
by the amino terminal domain (D1) of receptors (Rossmann et al., 2002).
PVR/CD155. Cell binding and entry of PVs 1-3 rely, as determined so far, on
one receptor, the poliovirus and vitronectin receptor PVR (CD155)
(Mendelsohn et al., 1989). PVR contains three extracellular Ig–like domains
and a short cytoplasmic tail (Koike et al., 1991). It shares significant
homology with nectins (Hogle, 2002), which are adhesion proteins related to
herpes virus entry (Geraghty et al., 1998). PVR interacts with the dynein light
chain that may direct its retrograde axonal transport in endocytic vesicles
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(Mueller et al., 2002) and it is involved in NK-mediated killing of tumour
cells (Reymond et al., 2004).
Several lines of evidence suggest that the first N-terminal domain (D1) of
PVR is responsible for virus binding and infection (Koike et al., 1991). The
cytoplasmic domain of PVR is not involved in the PV entry process and thus
signalling may not be important for PVR behaving as a virus receptor (Koike
et al., 1991). Since the crystal structure of PVR has not yet been solved, the
differences in the interpretation of the homology-built models of PV-receptor
interactions exist. Several authors have suggested that the D1 of PVR binds to
both outer (=south) and inner (=north) walls of the viral canyon and interacts
also with the floor of the canyon (Belnap et al., 2000b; He et al., 2000). Thus,
the receptor seems to bridge the virus canyon. In contrast, Xing and co-
authors claimed that PVR does not interact with the bottom of the canyon.
They have described the PVR as boot-like in shape, the tip of the foot
contacting the south wall of one protomer and the heel laying on a protrusion
in the neighbouring one (Xing et al., 2000).
ICAM-1. The major group HRVs, such as HRV14 and HRV16 (Greve et al.,
1989; Staunton et al., 1989; Tomassini et al., 1989), and CAV21 (Shafren et
al., 1997) interact with an intercellular adhesion molecule-1 (ICAM-1).
ICAM-1 contains five Ig-like domains. It regulates leukocyte adhesion, and
its natural ligands are integrins (Staunton et al., 1988). In cryo-electron
microscopy (cryo-EM) and X-ray crystallography studies, the D1 domain of
ICAM-1 was found to interact primarily with the floor and south wall of the
HRV canyon (Olson et al., 1993; Bella et al., 1998; Kolatkar et al., 1999).
The orientation of the ICAM-1 molecule with respect to the virus surface is
almost the same between HRV14 and HRV16 but different from CAV21
(Xiao et al., 2001; Rossmann et al., 2002).
CAR. A coxsackie-adenovirus receptor (CAR) functions as a receptor for the
six CBV serotypes as well as for certain adenoviruses (Bergelson et al., 1997;
Tomko et al., 1997). CAR is a broadly distributed type I membrane
glycoprotein of the Ig-family and it has only two Ig-like extracellular
domains, thus being shorter than PVR or ICAM-1 (Tomko et al., 1997). It is a
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component of the tight junctions and thus it is involved in regulating the
passage of macromolecules and ions across cell monolayers (Cohen et al.,
2001). CBVs and adenoviruses bind to different but overlapping sites of
domain 1 in CAR (He et al., 2001). Human, mouse and zebrafish CAR can
bind to CBV3, and conserved residues in the CBV3 footprint suggest that the
binding is clustered in the canyon region (Bergelson et al., 1998; Petrella et
al., 2002). Also, cryo-EM reconstruction of the full-length CAR in complex
with CBV3 showed that the D1 domain of the receptor binds to the CBV3
canyon (He et al., 2001). The cell-associated and soluble forms of CAR can
induce the conformational alterations in the viral capsid (Milstone et al.,
2005).
The binding of the IgSF-like receptor to a canyon of picornaviruses can lead
to conformational changes in the viral capsid, as studied most extensively
with PVs (Hogle, 2002). PV can undergo structural alterations when it is
exposed to cell-associated or soluble receptors (Arita et al., 1998). These
changes in virus conformation have been studied using cryo-EM
reconstruction, X-ray crystallography and CsCl- or sucrose gradient
centrifugation methods. In linear sucrose gradient ultracentrifugation, the
different conformations of viral capsids are sedimented based on their
velocity. The sedimentation is expressed as Svedberg’s coefficient of 160S for
intact capsid, 135S for capsid lacking VP4 and 80S for capsid lacking VP4
and the genomic RNA (Hogle, 2002). However, the sedimentation
coefficients may vary between different picornaviruses, and, moreover, some
forms of viral capsids might be too unstable to be recognized by this method.
As proposed in a current model for PV uncoating and host cell entry, the
receptor acts as a catalyst, which, after PV binding, is able to trigger the
externalisation of VP4 and the N termini of VP1. As a result, N-terminal
helices of VP1 are inserted into and rearranged in the lipid membrane,
resulting in a pore. The viral RNA can be released into the cytoplasm through
the pore when a plug formed by VP3 is removed (Belnap et al., 2000a).
Whether this pore is formed in the plasma membrane or in the membrane of
intracellular membranous vesicles is still unknown.
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Other examples of picornavirus receptors
DAF. A complement regulatory protein, decay accelerating factor (DAF;
CD55) acts as a receptor for several echovirus serotypes (Bergelson et al.,
1994a; Ward et al., 1994; Clarkson et al., 1995; Powell et al., 1998) and
enterovirus 70 (Karnauchow et al., 1996) as well as a secondary receptor for
CAV21 (Shafren et al., 1997) and CBVs 1, 3, and 5 (Bergelson et al., 1995;
Shafren et al., 1995)(Fig. 4, Table 2). DAF is expressed in most mammalian
cells and it consists of four short consensus repeats (SCRs) and a
glycosylphosphatidylinositol anchor (GPI) (Medof et al., 1987). EV7
(Clarkson et al., 1995; He et al., 2002) and CBV3 (Bergelson et al., 1995)
bind to a region near or in the third SRC domain, but enterovirus 70
(Karnauchow et al., 1998) and CAV21 (Shafren et al., 1997) interact with the
first SRC domain. In EV7, DAF binds around the two-fold axes (He et al.,
2002) and it cannot induce conformational changes in the viral capsid (Powell
et al., 1997). Accordingly, interaction with DAF is not sufficient to initiate the
conformational alterations of CBV3 (Milstone et al., 2005). Therefore, DAF
interactions with enteroviruses differ remarkably from IgSF receptor-
picornavirus interactions.
VLDL-R. The minor group HRVs bind to a very-low-density lipoprotein
receptor (VLDL-R) (Hofer et al., 1994), which normally shuttles the VLDL-
particles into the host cell. The binding site of VLDL-R in HRV2 structure is
on a small, star-shaped dome around the five-fold axes (Hewat et al., 2000).
The binding of HRV2 to its receptor leads to clathrin-mediated endocytosis,
followed by uncoating under conditions of low endosomal pH (Bayer et al.,
2001).
Heparan sulphate. The field isolates of FMDVs, which normally bind to
integrins (Berinstein et al., 1995), can adapt to use heparan sulphate as a
receptor in laboratory cell cultures (Jackson et al., 1996; Neff et al., 1998).
The binding site of heparan sulphate is a shallow depression on the virus
surface, located at the junction of VP1, VP2 and VP3 (Fry et al., 1999).
Heparan sulphate may also be involved in attachment of certain echoviruses
on the cell surface (Goodfellow et al., 2001).
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Sialic acid(s) may act in enterovirus 70 binding and productive infection
(Alexander and Dimock, 2002). This has been confirmed by Haddad et al.,
who suggested that enterovirus 70 is able to use sialyted receptors other than
DAF in cultured human leukocyte cell lines (Haddad et al, 2004). Also, the
presence of sialic acid on cellular receptors is required for HRV87 attachment
and infection (Uncapher et al., 1991).
β2 microglobulin. On the cell surface, β2m is expressed in association with
MHC class I molecules. Antibodies against β2m have been found to prevent
many enterovirus infections, suggesting that β2m could act as a secondary
receptor for many serotypes of echoviruses, including EV1 (Ward et al.,
1998) as well as for some coxsackieviruses (Triantafilou et al., 1999).
However, the exact role of β2m in virus binding has remained unclear and it
may, more probably, have an indirect role in virus-cell interactions.
3. Internalization of picornaviruses into host cells
The aim for the virus is to enter a suitable site, either the cytoplasm or the
nucleus of the host cell, for replication. Most nonenveloped viruses use
endocytosis which carries them into the host cell through the membrane
barrier and cortical actin network (Fig. 7). For a long time, clathrin-mediated
endocytosis was regarded as the main entrance route. More recently,
investigations have led to recognition of other significant endocytic pathways,
including lipid rafts, caveolae, macropinocytosis and non-caveolae and non-
clathrin -dependent mechanisms (Johannes and Lamaze, 2002). It can be
expected that additional endocytic pathways will be identified in the future
(Damm et al., 2005; Kirkham et al., 2005). The data accumulated on virus
endocytosis indicate that many viruses can switch from one uptake
mechanism to another and simultaneously utilize several endocytic routes in
order to enter efficiently into the host cell (Sieczkarski and Whittaker, 2005).
So far, picornaviruses have been reported to use clathrin-, caveolae-, and lipid
raft- dependent uptake mechanisms. Instead, PV may protrude its genome into
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the host cell directly from the plasma membrane by generating a pore into the
membrane (Hogle, 2002), as explained in the Chapter 2.3.
Figure 7. Endocytic mechanisms of virus entry. In addition to endocytic uptake
mechanisms, nonenveloped viruses, such as PV, may release their genome into the
cytoplasm through a pore, formed at the plasma membrane. Some enveloped viruses
introduce their genome into the host cell via direct membrane fusion events.
Viruses have served as excellent tools for the studies of the cellular endocytic
mechanisms since their uptake is easier to follow compared to smaller natural
ligands (Pelkmans and Helenius, 2003). On the other hand, the lack of
specific markers of different entry pathways has made it challenging to define
the uptake routes for viruses. Inhibitors of cellular functions are efficient but
rather inaccurate in studies of endocytosis. Usually, dominant-negative
mutants derived from both structural and regulatory proteins of endocytic
machinery are more specific than chemical inhibitors (Sieczkarski and
Whittaker, 2002; Pelkmans and Helenius, 2003). However, in some cases the
results obtained with dominant negative mutant proteins have not been
interpreted correctly. For example, dominant negative dynamin 2 was thought
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to affect only the clathrin route but later studies have revealed its inhibitory
effect on other routes of entry, including caveolar endocytosis (Damke et al.,
1994; Henley et al., 1998; Oh et al., 1998).
Microscopical methods are certainly required for detailed studies on endocytic
routes. The (immuno)electron microscopy (EM) has been widely used to
define the morphology of intracellular structures involved in virus uptake
(Helenius et al., 1980; Kartenbeck et al., 1989). Prelabelled cellular
molecules, characterized to utilize a certain endocytic pathway, as well as
specific antibodies against cellular proteins have been applied in
immunofluorescence microscopy. Most recently, real-time microscopy of
living cells has provided a sophisticated method to follow the trafficking of
fluorescently tagged or prelabelled proteins and viruses, such as adenovirus
(Suomalainen et al., 1999), simian virus 40 (Pelkmans et al., 2001) and
influenza virus (Lakadamyali et al., 2003). The approaches reviewed briefly
above have been applied in this thesis to the studies of endocytosis of EV1.
3.1 Clathrin -mediated endocytosis
Clathrin-coated pits are formed from a basketlike framework of clathrin
(Kirchhausen, 2000). Several proteins, including adaptor complex AP-2 and
dynamin GTPase, regulate the assembly and fission of the pits (Takei and
Haucke, 2001). Upon ligand binding to its receptor in the clathrin-coated pits,
the pits pinch off to form intracellular clathrin-coated vesicles (Brodsky et al.,
2001). Within seconds, clathrin-coated vesicles shed their coat and fuse with
early endosomes (EEs). After 5 to 15 minutes, EEs fuse with late endosomes
(LE) that have a more acidic pH. Endocytosed receptors do not always reach
the LEs but, instead, they can be recycled back to the cell surface in
approximately 20 min. Some molecules are transported from LEs into
lysosomes, which contain hydrolytic enzymes for degradation.
Many viruses, including adenoviruses, alphaviruses, hantaviruses,
orthomyxoviruses, parvoviruses, and some picornaviruses (DeTulleo and
Kirchhausen, 1998; Marsh and Pelchen-Matthews, 2000) take advantage of
clathrin-mediated endocytosis.
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The clathrin-mediated endocytosis of the minor group HRVs, especially
HRV2, is probably the most extensively studied entry mechanism among
picornaviruses (Prchla et al., 1994). The recent report on HRV2 entry showed
that the infection can be inhibited by the dominant negative mutant of
dynamin 2 GTPase as well as by more specific dominant-negative inhibitors
of clathrin-mediated endocytosis, such as the SH3 domain of amphiphysin or
the C-terminal domain of AP180 (Snyers et al., 2003). However, some studies
have challenged the endocytosis of HRV2 via clathrin-coated pits (Bayer et
al., 2001; Huber et al., 2001).
The endocytosis of HRV2 is mediated by the VLDL-R, which is dissociated
from the virus in EEs (Brabec et al., 2003). The virus reaches LEs, where it
undergoes conformational alterations, dependent on low pH (Bayer et al.,
2001; Huber et al., 2001). Upon uncoating, the viral RNA is transferred into
the cytoplasm across a pore in the endosomal membrane and viral capsid
proteins may be transported to lysosomes for degradation (Prchla et al., 1994;
Prchla et al., 1995; Schober et al., 1998).
The entry of major group HRVs, such as HRV14, proceeds also via clathrin-
coated pits to EEs (Schober et al., 1998). Based on some studies, the entry
and uncoating of HRV14 appears to be pH-dependent (Grunert et al., 1997;
Nurani et al., 2003). However, it has also been suggested that the virus could
cause a lytic disruption of EEs by a receptor-dependent manner in the absence
of endosomal acidification (Bayer et al., 1999). This could lead to release of
viral RNA into the cytoplasm (Schober et al., 1998; Bayer et al., 1999).
HPEV1, which binds to αv integrins on the cell membrane, enters the cells
through clathrin-mediated endocytosis (Joki-Korpela et al., 2001). The
receptor, αvβ3 integrin, does not colocalize intracellularly with the virus.
After 5 min of internalization, the virus is in EEs, and after 30 min, it is found
in the LEs. After 30-60 min, the capsid proteins are located in both the
endoplasmic reticulum (ER) and the cis-Golgi network. The viral RNA may
be released early during the entry process, since depolymerization of
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microtubules did not block viral infection even though it inhibited movement
of HPEV1 capsid proteins to LEs (Joki-Korpela et al., 2001).
A recent study of internalization and trafficking mechanisms of CAR-
dependent strain of CBV3 revealed that the virus enters cells via clathrin-
coated pits (Chung et al., 2005). The virus was detected in the pits and in
clathrin-coated vesicles by immuno-EM. CBV3 was also found in clathrin-
coated pits and vesicles and in EEs in immunofluorescent labelling of infected
cells. Moreover, endosomal acidification and dynamin 2 were shown to be
essential factors for the infection (Chung et al., 2005).
In addition to direct uncoating on the cell membrane, clathrin-mediated
endocytosis has been suggested for PVs (Zeichhardt et al., 1985;
Willingmann et al., 1989; Kronenberger et al., 1998). However, PV infection
is not obligatorily dependent on dynamin 2 (DeTulleo and Kirchhausen,
1998), a marker of clathrin- and caveolae-mediated pathways. More recently,
PV infection was shown to be inhibited in the presence of cholesterol
depletion. However, the virus did not localize in the detergent-insoluble
microdomains (Danthi and Chow, 2004). Therefore, it was suggested that PV
infection and the release of viral RNA are dependent on cholesterol but not on
lipid rafts. Thus, further investigations are required to clarify the entry
mechanisms of PVs.
3.2 Lipid raft -mediated endocytosis
Lipid rafts are membrane microdomains, enriched in cholesterol, specific
glycosphingolipids and several signalling molecules (Simons and Ikonen,
1997), as well as integrins (Brown, 2002). Rafts are rather small dynamic
structures that are stabilized through interactions with the cytoskeleton
(Kenworthy, 2002). In response to various stimuli, lipid rafts can aggregate
into larger platforms. Cell surface caveolae are highly specialized type of lipid
rafts, and they contain caveolin-1 as their main protein component
(Kurzchalia and Parton, 1999). Even though several studies during last
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decades have focused on the lipid rafts, their size, dynamics and composition
are still under debate (Mayor and Rao, 2004).
Endocytosis via lipid rafts can be dependent on or independent of dynamin 2,
but otherwise, this internalization pathway is rather poorly known (Pelkmans
and Helenius, 2003). However, recent studies on alternative entry pathways of
simian virus 40 (SV40) and cholera toxin (CTX) may illuminate the raft-
dependent entry mechanisms (Damm et al., 2005; Kirkham et al., 2005).
Rafts are not only involved in viral endocytosis but also in the assembly and
budding of viruses (Suomalainen, 2002). Viruses that may use rafts or raft-
located receptors for the endocytosis and/or fusion events include group A
rotaviruses (Isa et al., 2004), avian sarcoma and leucosis virus (Narayan et al.,
2003), certain enteroviruses (Stuart  et al., 2002a; Triantafilou and
Triantafilou, 2003, 2004), SV40 (Damm et al., 2005), and HIV (Manes et al.,
2000).
Recently, EV11 was reported to be endocytosed via lipid rafts and/or
caveolae (Stuart et al., 2002a). Interestingly, the EV11 mutant that does not
bind to DAF, a receptor for EV11, was not internalized through rafts,
indicating that internalization is specifically directed by the receptor. Indeed,
DAF contains a GPI-anchor, and it is found in plasma membrane lipid rafts
(Bergelson et al., 1994a; Mayor et al., 1994). EV11 is also able to infect cells
not expressing caveolin-1. In such a cell line, similarly to the cell line
expressing caveolin-1, the virus was copurified with detergent insoluble
membrane microdomains within 30 min-1 h p.i. Thus, EV11 may use both
caveolae and non-caveolar lipid rafts in its entry process. Also, an intact actin
cytoskeleton and microtubule network are required prior to uncoating of the
virus (Stuart et al., 2002a).
A recent paper suggested that lipid raft microdomains could also play a role in
the entry process of CAV9 (Triantafilou and Triantafilou, 2003). The viral
receptor, αvβ3 integrin as well as possible accessory molecules, such as
GRP78 and MHC class I molecule, were found in increased concentrations in
lipid rafts when studied at 30-60 min after CAV9 binding to cells. Moreover,
raft-interfering agents inhibited CAV9 infection. Also, another enterovirus,
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CBV4, was reported to use rafts for efficient entry into the Golgi (Triantafilou
and Triantafilou, 2004). However, the role of caveolae cannot be ruled out in
the endocytic processes of these viruses because it was not examined.
3.3 Caveolae -mediated endocytosis
The name of caveolae is derived from Latin and means little caves (Palade,
1953). Caveolae are flask-shaped invaginations in cell membranes, formed
from a structural coat protein caveolin-1 (Rothberg et al., 1992; Schlegel and
Lisanti, 2001). Cholesterol binds to caveolin and seems to be necessary for
the structure of caveolae (Murata et al., 1995; Ikonen and Parton, 2000).
Moreover, cholesterol is involved in signalling and trafficking functions of
caveolae. Caveolae contain several signalling proteins, such as protein kinase
C (Mineo et al., 1998), GTP binding proteins and non-receptor tyrosine
kinases (Sargiacomo et al., 1993; Lisanti et al., 1994). Caveolae are proposed
to act as "organized transducing centres that concentrate key signalling
molecules in a compartment to create rapid, efficient and specific
transmission of signals from the cell surface into the cell" (Lai, 2003). On the
other hand, caveolae contain molecular machinery for regulated, receptor-
mediated endocytosis and transcytosis of selected ligands via vesicle budding,
docking and fusion (Schnitzer et al., 1995).
Caveolae are used in the entry of natural ligands (e.g. albumin)(Schnitzer et
al., 1994), toxins (e.g. cholera toxin; CTx)(Montesano et al., 1982; Nichols,
2002), bacteria (e.g. E.coli) (Shin et al., 2000) and viruses (Pelkmans and
Helenius, 2002). The binding of a ligand to a receptor in caveolae may trigger
the internalization of caveolae. The GTPase dynamin, depolymerization of
actin and specific signalling events are required for the internalization (Parton
et al., 1994; Henley et al., 1998). The internalized caveolar vesicles of 60-70
nm can deliver the cargo to cytoplasmic organelles, caveosomes (Pelkmans et
al., 2001). In addition, when recruited by small GTPases such as Rab5, the
caveolar vesicles can fuse with other organelles such as EEs and form distinct
and stable membrane domains (Pelkmans et al., 2004).
Caveosomes have been defined as pre-existing organelles, enriched in
caveolin-1 and devoid of markers of classical endocytic pathways and
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biosynthetic organelles, including Rab GTPases 4, 5, 6, 9, and 11, and
endosomal and lysosomal markers (Pelkmans et al., 2001; Pelkmans and
Helenius, 2002, 2003). A significant difference with endosomes is the pH-
neutrality of caveosomes (Pelkmans et al., 2001). The ligands may be
transported to caveosomes also directly from lipid rafts by a mechanism that
does not involve cell surface caveolae, caveolar vesicles or clathrin-coated
vesicles (Damm et al., 2005; Kirkham et al., 2005). Caveolar vesicles and
caveosomes can further deliver their cargo to the endosomes, Golgi,
endoplasmic reticulum (ER) or lysosomes, often through microtubule-directed
movements (Conrad et al., 1995; Nichols, 2002).
Viruses using caveolar endocytosis. Simian virus 40 (SV40) was the first
virus characterized to use caveolae-mediated endocytosis (Anderson et al.,
1996). Many other viruses, e.g. EV1 (Marjomäki et al., 2002), filoviruses
(Empig and Goldsmith, 2002), some coronaviruses (Nomura et al., 2004) and,
in some cases, polyomaviruses (Richterova et al., 2001; Eash et al., 2004;
Gilbert and Benjamin, 2004) can also enter the cells via caveolae. So far, EV1
is the only picornavirus shown to utilize caveolar endocytosis, as discussed in
the Results and Discussion of this thesis. Because the uptake of SV40 to
caveosomes has been investigated extensively, it is reviewed here in detail
(Pelkmans and Helenius, 2003) (see Fig. 10., p.67)
SV40 is a nonenveloped DNA virus and it has an icosahedral capsid of 50 nm.
The capsid is composed of 360 subunits of the major coat protein VP1 and
containing minor amounts of VP2 and VP3. On the cell surface, SV40 binds
to MHC class I molecule (Anderson et al., 1996; Stang et al., 1997) and
ganglioside GM1, located into lipid rafts (Tsai et al., 2003). Within 20
minutes, the mobile virus particles are trapped into caveolae (Pelkmans et al.,
2001). As a consequence of SV40 binding to its receptor, intracellular
caveolar vesicles are recruited to the membrane for formation of additional
caveolae. The MHC class I molecule is transported from non-caveolar region
to the cell surface caveolae upon the virus binding but the receptor is not
endocytosed with a virus (Stang et al., 1997; Anderson et al., 1998).
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However, the ganglioside GM1 may be transported with SV40 from the
plasma membrane to the ER (Tsai et al., 2003).
In caveolae, SV40 triggers a signal transduction cascade (Chen and Norkin,
1999) that leads to actin cortex depolymerization, local tyrosine
phosphorylation and production of phosphatidyl 4,5-bisphosphate (Pelkmans
et al., 2002; Pelkmans and Helenius, 2003). Subsequently, both actin and
dynamin are recruited to caveolae and actin tails are formed at the site of
caveolae internalization (Pelkmans et al., 2002). These events lead to
relatively slow but efficient internalization of virus-containing caveolae to the
cytosol.
A recent paper reported that some of incoming SV40 colocalizes with Rab5a,
a GTPase normally located into EEs (Pelkmans et al., 2004). When a
dominant active-mutant of Rab5a was expressed in the cells, SV40 was
trapped into a greater extent into endosomes, which also contained caveolin-1.
Even though caveolar vesicles, which carry SV40 particles, transiently
interact with EEs also under normal conditions, this pathway is not obligatory
for SV40 infection (Pelkmans et al., 2004).
Virus-carrying caveolar vesicles fuse with caveosomes after the next 40 min
to 3 h, making caveosomes increasingly dynamic (Pelkmans et al., 2001). A
recent paper reported that SV40 can, in mouse knock-out cells lacking
caveolin-1, enter the caveosome-like organelles via an alternative pathway
that is not dependent on caveolin-1 or dynamin 2 but involves tyrosine
phosphorylation events (Damm et al., 2005). In contrast to caveolar uptake,
this pathway appears to be more rapid and results in removal of the virus from
cell surface lipid rafts into caveosome-like organelles through non-caveolar,
non-clathrin -coated vesicles. Interestingly, this entry pathway may also be
utilized by SV40 in cell lines that contain caveolin-1 (Damm et al., 2005).
From caveosomes, SV40 is carried to the ER in long, tubular vesicles that
move along microtubules (Pelkmans et al., 2001). The majority of virus
particles remain in the smooth ER for up to 16 h or longer (Norkin et al.,
2002). The details concerning the transport of viral particles to the nucleus for
replication remain unclear.
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4. Host cell gene expression during picornavirus infection
Viruses are able to cause dramatic changes in host cells in order to maximise
the efficiency of their replication and to overcome the host cell defence
mechanisms. The modifications of cellular functions can be brought about by
interactions of virus with its receptor, by viral replication and by direct
interference with the functions of cellular proteins and organelles (Knipe et
al., 2001).
To obtain optimal conditions for replication, picornaviruses can take over the
host cell translation machinery and cause inhibition of host cell protein
synthesis (shut-off). Moreover, cellular transcription can be inhibited and host
cell gene expression pattern altered during the infection (Racaniello, 2001).
At the molecular level, these changes result in the activation of a variety of
cellular pathways, including those related to stress response, cytokine
production and apoptosis (programmed cell death). In addition, picornaviruses
can remodify cellular membranes, interfere with intracellular protein
trafficking and alter numerous other cellular functions (Carrasco et al., 2002).
At the end of the picornavirus replication cycle, the exploitation of host cell
machinery is usually observed as a cytopathic effect (CPE), which includes
cell rounding and detachment and, finally, cell death (Racaniello, 2001).
Picornaviruses can also exhibit apoptotic activity to release the progeny viral
particles from the host cell and, on the other hand, they can induce
antiapoptotic activities to prevent premature cellular death (Tolskaya et al.,
1995). All these events in host cells during the infection affect the viral
pathogenesis in the target tissue.
4.1 cDNA array studies of host cell gene expression in enterovirus
infection
The traditional approaches, such as Northern blot analysis, have been
successfully used in measuring changes in cellular mRNA expression during
viral infections. More recently, cDNA (micro)array techniques, which allow
the simultaneous determination of the levels of thousands of specific mRNA
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species, have been applied in the characterization of host cell gene expression
during virus infections (Jenner and Young, 2005).
cDNA arrays
For cDNA array analysis, RNA samples can be extracted from tissues or from
cultured cells. The samples are reverse-transcribed into cDNA in the presence
fluorescently or radioactively labelled nucleotides. cDNAs are then hybridised
either onto membranes or microarrays, carrying the cDNA clones (cDNA
membrane arrays, cDNA microarrays) or oligonucleotide sequences (Duggan
et al., 1999). The signal is detected either by measuring the fluorescence
intensities or radioactivity of the hybridised spots (Fig. 8).
Figure 8. The general principles of the cDNA array technique, used for screening of
the host cell gene expression during virus infection. The total RNA samples are
isolated from uninfected control cells and infected cells for synthesis of radioactively
labelled cDNAs. cDNA transcripts are then hybridised to parallel membranes, which
have been spotted with hundreds or thousands of cDNA clones.
The ability to screen a wide variety of host cell genes with cDNA arrays
provides an efficient method to clarify gene alterations during viral
pathogenesis (Jenner and Young, 2005). In addition, the method is relatively
fast when considering the amount of data that is generated (Brown and
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Botstein, 1999). However, there are also some drawbacks in the technique.
Reproduction of the results is difficult because the phase of cell cycle, quality
of input virus, and temperature changes during collection of samples may
vary between the parallel experiments. Sensitivity of the cDNA (micro)array
system is dependent on many factors, such as the quality of samples, and it
may also vary between the experiments, leading to wrong interpretation of the
results. The selection of the most reliable control genes (house-keeping genes)
is challenging in studies of virus infections, because the infection may result
in altered expression of normally "stable" genes. Also, the tools for "data
mining", such as statistical analysis and interpretation of the data, are critical
(Bassett et al., 1999), even though profiling of affected genes into functional
clusters has greatly facilitated the elucidation of results.
Many other factors than those observed at the gene expression level may
contribute to the onset and severity of the disease in pathogenetic models, and
thus, not too far-reaching conclusions from the results of cDNA array analysis
should be drawn. Despite these concerns, cDNA array screening may help to
explain how the host cell "sees" a virus at gene expression level and, on the
other hand, how viruses exploit the host cell machinery (Manger and Relman,
2000).
Studies of enterovirus infection with cDNA arrays
The first cDNA array study of picornavirus infection concentrated on the
identification of eucaryotic mRNAs that are translated in the presence of PV-
induced shut-off of host cell protein synthesis (Johannes et al., 1999). Here,
the cellular mRNAs associated with polysomes of PV-infected HeLa cells
were hybridised to the cDNA microarrays (Johannes et al., 1999). Among the
7000 genes studied, around 0.3% of genes showed changes over 1.7-fold at 3
h p.i. The genes enriched in polysomes were encoding, for example, for
"immediate early" genes, proteins of mitogen-activated-protein kinase
(MAPK) pathways, oncogenes, DNA binding proteins and cellular receptors.
Other cDNA array studies of enterovirus infections have focused on CBV4 -
induced pancreatitis in mice (Ostrowski et al., 2004), and on the pathogenesis
of CBV3 -induced myocarditis in mice (Taylor et al., 2000). Of the 7000
genes screened, approximately 2% had changed levels of expression during
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the CBV3 infection in the myocardium (Taylor et al., 2000). The affected
genes were clustered into functional groups of host defence, cell signalling,
cell division, cell structure/motility, protein and gene expression, cell
metabolism and mitochondrial genes. In addition to pathogenic mouse
models, cDNA arrays have been applied to the studies of CBV3 infection in
HeLa cells (McManus et al., 2002). Even though the host cell gene expression
patterns are somewhat different during enterovirus infections, common
clusters of activated genes can be found, as discussed below.
Immediate early (IE) genes. The expression of IE genes is rapidly and
transiently induced as a response of extracellular stimuli to alter patterns of
cellular gene expression (Sng et al., 2004). The expression of these genes is
dependent only on modification of factors already present in cells (Thomson
et al., 1999). IE genes encode for chemo-attractants, cytoplasmic enzymes,
ligand-dependent transcription factors and inducible transcription factors,
such as fos (c-Fos, FosB, Fra-1, Fra-2), jun (c-Jun, JunB, JunD) and
activating transcription factors (ATF) (e.g. ATF2, ATF3). The gene products
of these families are the main components of transcription factor AP-1 that
controls the transcription of genes involved in cell proliferation,
transformation, survival and death (Shaulian and Karin, 2002).
In the cDNA array analysis of PV-infected cells, several IE genes were found
to be enriched in polysomes and their expression was increased compared to
the uninfected control cells (Johannes et al., 1999). The upregulated IE genes
included Pim-1 proto-oncogene, c-myc proto-oncogene, ATF3, and
transforming growth factor-β-inducible early growth response protein
(TIEG). Correspondingly, ATF3 as well as IE genes c-jun and c-fos have been
found to be transiently overexpressed at early time points in CBV3-infected
HeLa cells (McManus et al., 2002). In addition, gene profiling of CBV3-
infected mouse hearts has revealed an increased expression of a related gene,
ATF4, during the inflammatory phase of infection (Taylor et al., 2000). ATF3
and ATF4 are transcriptionally upregulated in most of the cell stress responses
(Rutkowski and Kaufman, 2003). They can either act as transcriptional
repressors or bind to c-jun in order to facilitate cellular transcription.
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Genes encoding proteins of MAPK pathways. The individual IE genes as
well as AP-1 are regulated by mitogen-activated protein kinases (MAPKs),
such as extracellular signal-regulated kinase (ERK) -1/2, the Jun-N-terminal
kinase/stress-activated protein kinase (JNK/SAPK), p38 MAPK and ERK5
(Chang and Karin, 2001). ERK pathways mainly respond to mitogens and
growth factors, whereas JNK/SAPK and p38 are activated by environmental
changes and inflammatory cytokines. MAPKs mediate apoptosis, cell
transformation and responses to cell stress and cytokines (Chang and Karin,
2001).
The activation of MAPK pathways at the protein level has been observed
during several enterovirus infections, including EV11, EV12, CBV3 (Huber,
1999) and EV1 (Huttunen et al., 1998) infections. The activation of ERK1/2
during CBV3 infection leads to virus-induced CPE and apoptosis (Huber,
1999; Luo et al., 2002). The regulators of MAPK pathway, such as
MAPKK3b gene, were associated in increased amounts in polysomes in PV-
infected cells in the cDNA microarray study (Johannes et al., 1999). The
authors speculated that the activation of p38 MAPK pathway by MAPKK3b
during PV infection could, for example, lead to production of inflammatory
cytokines.
IRES -containing genes. In the presence of a complete enterovirus-induced
inhibition of host cell protein synthesis (=shut-off), only IRES-containing
viral RNA or host cell mRNAs that carry an IRES can be translated (Pelletier
and Sonenberg, 1988). The shut-off effect is mainly caused by a cleavage of
the translation initiation factor eIF4GI/II by enteroviral protease 2A (Knipe et
al., 2001). After the cleavage, eIF4G cannot attach via eIF4E to the 5' capped
structures in the cellular RNAs to initiate translation. Pim-1 and c-myc mRNA
levels increased during PV infection in HeLa cells. Both of these genes
contain an IRES element, which enables their translation in the presence of
PV-induced shut-off. Pim-1 encodes a serine-threonine protein kinase that can
cooperate with c-myc during cellular transformation (Wang et al., 2001). c-
myc IRES has been shown to be activated during the mitosis and via MAPK
p38 during apoptosis (Stoneley et al., 2000).
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4.2 The effects of EV1 on host cell gene expression
Transcription of IE genes c-jun, junB, and c-fos has been demonstrated to
increase after 5-10 h of EV1 infection by Northern blot analysis of the
infected cells (Huttunen et al., 1997) and by analysis of the transcription rates
of the genes (Huttunen et al., 1998). Activation of both p38 MAPK and ERK
1/2 pathways led to increased c-fos expression whereas p38 MAPK was the
main inducer of junB expression (Huttunen et al., 1998).
In these studies, it was of interest whether the virus-integrin interaction could
lead to IE gene activation, which is observed as a consequence of type I
collagen binding to the α2β1 integrin (Rana et al., 1994). As a result, EV1-
receptor interactions did not seem to influence the regulation of IE genes
during the infection. However, post-attachment events were required for IE
gene activation (Huttunen et al., 1997). This idea was supported by the fact
that the IE genes were not induced in EV1-infected cells in the presence of
antiviral compound WIN, which interferes with receptor binding and
uncoating of the virus. In addition, the transfection of viral RNA into the cells
was sufficient to induce the activation of junB (Huttunen et al., 1997).
Moreover, the induction of IE genes was described not to be unique for EV1-
α2β1 integrin interaction because a similar activation pattern of IE genes was
observed in cells infected with EV7 and with PV1, which use another receptor
for cell surface binding (Huttunen et al., 1997).
However, according to a recent study by Upla and colleagues, the interaction
of EV1 with α2β1 integrin is able to trigger signalling events, such as PKCα
phosphorylation and activation of MAPK ERK1/2 (Upla et al., 2004). This is
in agreement with the fact that binding of natural ligands to integrins can lead
to regulation of the MAPK pathway(s) (Juliano et al., 2004). Interestingly, the
activation of ERK1/2 during CBV3 infection (Huber, 1999; Luo et al., 2002)
may also lead to the expression of IE genes. The early activation of ERK1/2 is
triggered by cell-surface binding and internalization of CBV3, but the late
activation requires virus replication. The similar two-step activation of
MAPKs could also occur in EV1 infection, thus explaining the somewhat
contradictory results (Huttunen et al., 1997, 1998; Upla et al., 2004).
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AIMS OF THE STUDY
The initial aims of this thesis were to investigate the interactions of EV1 with
α2β1 integrin, to characterize the endocytic uptake mechanism(s) for EV1,
and to study the host cell gene expression during enterovirus infection.
SPECIFIC AIMS:
Interactions of EV1 with α2β1 integrin:
•  To study the attachment of EV1 to the cell surface and to α2β1
integrin
•  To study conformational changes and uncoating of EV1 as a
consequence of the cell surface/receptor binding
•  To produce the intact EV1 for structural cryo-EM studies of the
EV1-α2I domain complex
• To define the binding sites of α2I domain in EV1 capsid
Endocytic uptake mechanisms for EV1:
• To define how EV1 enters the host cell
•  To characterize the role of caveolae and caveosomes in EV1
internalization process
• To illustrate the endocytic route of EV1 into caveosomes in more
detail using fluorescently labelled virus in real-time live
microscopy
 Intracellular effects of EV1 infection:
• To screen the alterations in cellular gene expression during EV1,
CBV4 and PV1 infections by using a new cDNA array method
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MATERIALS AND METHODS
The original publications in which the methods have been employed are indicated in
brackets. The immuno-electron microscopy (EM) (I), solid phase binding assays (I)
and cryo-EM-modelling of EV1-α2I domain structure (I) were completely carried out
by the collaborators, and are explained in detail in original publications I and II.
1. Viruses (I-IV)
Viruses. EV1 (Farouk strain), CBV4 (JVB), PV1 (Sabin) and SV40 were originally
obtained from the American Type Culture Collection (ATCC). EV1 was purified as
originally described by Abraham and Colonno (Abraham and Colonno, 1984).
Briefly, the infected cells and the supernatant were collected, and after three freeze-
thaw cycles, the virus was precipitated by PEG/NaCl and purified by
ultracentrifugation in 5-20% sucrose gradients. Purified CBV4 and PV were obtained
from M. Roivainen (National Public Health Institute, Finland). Purified SV40 was
obtained from L. Pelkmans (Swiss Federal Institute of Technology Zürich,
Switzerland)(Pelkmans et al., 2001). MOIs of 1-20 of purified viruses were used in
most of the experiments.
Radioactive labelling of viruses. To obtain radioactively labelled EV1 and PV1, the
infected cells were incubated in the presence of [35S]-methionine (50 µCi/ml;
Amersham Pharmacia Biotech) in Eagle minimal essential medium (MEM) deficient
in L-methionine (MEM-met) (GibcoBRL, Life Technologies) and purified as above.
Fluorescent labelling of EV1. The fluorescent labelling of purified EV1 (100-200 µg
of virus), with a ten times higher molar concentration of Texas Red-X succinimidyl
ester (Molecular Probes) or Alexa Fluor (AF)-594 succinimidyl ester (Molecular
Probes), was performed as described by Pelkmans et al. (2001). SV40, labelled with
Cy5, FITC or AF-594 dyes, was obtained from L. Pelkmans (Pelkmans et al., 2001).
2. Cell cultures (I-IV) and transfections (II, III)
Cells. The cell lines used in the studies were African green monkey kidney cell lines
(CV-1, GMK), human epitheloid carcinoma cells (HeLa-Ohio) and human
osteosarcoma cells (HOS, SAOS-2). All the cell lines were obtained from ATCC.
HOS-pα2AW (Riikonen et al., 1995) and SAOS-α2β1 cells (Ivaska et al., 1999b)
were generated from wild-type cell lines that normally lack endogenous α2 integrin
by transfection of cells with a vector carrying the α2 integrin subunit (Ivaska et al.,
1999b). SAOS-α1/α2β1 cells expressed the chimeric form of α2 subunit in which the
cytoplasmic domain of α2 was replaced by that of α1 integrin subunit (Ivaska et al.,
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1999b). SAOS-pAW cells, carrying the pAW vector, were used in control
experiments.
The cells were maintained in Dulbecco's MEM (DMEM; GibcoBRL), supplemented
with 10% foetal calf serum (FCS), 2 mM L-glutamine, 100 IU/ml penicillin, and 100
µg/ml streptomycin. Antibiotic G418 (200 µg/ml)(GibcoBRL) was added to
transfected SAOS and HOS cells. The infections were performed in the same media
but the concentration of FCS was reduced to 1% (infection media). Virus infections
were performed for 1 h on ice or alternatively for 1 h at 4°C to allow the binding of
the virus. The unbound virus was removed by washing and cells were transferred to
37°C.
Transfections. The transient transfections of CV-1 and/or SAOS-α2β1 cells were
performed with Fugene 6 (Roche) or Superfect (Qiagen). N- or C-terminally GFP-
tagged constructs of caveolin-1 (GFP-caveolin-1 and caveolin-1-GFP,
respectively)(Pelkmans et al., 2001) and HA-tagged caveolin-3 and caveolin-3DGV
(Roy et al., 1999) were used to investigate the role of caveolar route in infection.
GFP-tagged wt dynamin 2 and dominant negative dynamin 2(K44A) (Cao et al.,
1998; Ochoa et al., 2000), GFP-tagged wt Eps15 and Eps15E∆95/295-GFP
(Benmerah et al., 1999) and c-myc tagged adaptor protein 180 with truncated C-
terminus (AP180C construct)(Ford et al., 2001) were also used in transfections. The
exact functions of the constructs mentioned above are explained in the Results and
Discussion. In addition, a myc-tagged transferrin receptor construct was used to mark
the clathrin -dependent endocytosis route.
3. Infectivity and binding assays (I-IV)
Plaque assay. The following plaque assay was used in several experiments: The
viruses were incubated with the cells on 6-well plates for 30 min at 37°C. After
removal of unbound virus, the cells were overlaid with 0.5 % carboxymethylcellulose
in infection media. After 2 days incubation at 37°C, the cells were stained with crystal
violet before counting of the plaques.
Infectivity titration. For determination of viral replication cycle, the cells were
infected with virus and collected at different time-points of infection. After three
freeze-thaw cycles, the amount of intracellular virus was determined by plaque assay.
Alternatively,  infectivity titration in GMK cells was performed to harvested samples.
After incubation for 7 days at 37°C, the cells were stained with crystal violet for the
determination of end-point titres.
Inhibitory assays with drugs. For inhibitory assays, CV-1 cells were preincubated
with different cellular inhibitors for 30 min at 37°C. Purified EV1 was allowed to
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bind to cells for 1 h at 4°C. After removal of the unbound virus, the cells were
incubated in the presence of the drugs for 6 h at 37°C. For testing the effects of
brefeldin A (BFA, Sigma), the CV-1 cells were incubated in the presence of the drug
(0.5-2 µg/ml) for 1 h at 37°C prior to the infection. Concentrations of the drugs used
were 5 µM bisindolylmaleimide (Sigma), 1-7 µg/ml of cytochalasin D (Sigma), 25-
250 µM genistein (Sigma), 0.13-1 µM latrunculin A (Molecular Probes), 0.1-0.75 µM
jasplakinolide (Molecular Probes), 10 mM methyl-β-cyclodextrin (Sigma), 33 µM
nocodazole (Sigma), 25 µg/ml nystatin (Sigma) together with 10 µg/ml progesterone
(Sigma), 1 µM okadaic acid (Sigma), 10 µM safingol (Sigma) and 1 mM sodium
orthovanadate (Calbiochem). The effects of the drugs on cellular functions are
explained in the original publication IV. After infection the cells were stained with
anti-EV1 antiserum for immunofluorescence microscopy or the infectivity of the virus
was determined by plaque assay.
Inhibition assay with the α2I domain. Plaque assay was used to test whether the
preincubation of viruses with their receptors could result in inhibition of the infection.
Prior to plaque assay, EV1 (200 plaque forming units; PFU) was incubated alone,
with different concentrations (0-1000 nM) of a recombinant glutathione-S-transferase
(GST) fusion protein of α2I (α2I-GST) (obtained from J. Käpylä, University of
Jyväskylä, Finland) or with GST for 1 h at 37° C. Corresponding incubations were
performed for PV1 and PVR-Fc, obtained from L. Xing (Karolinska Institute,
Huddinge, Sweden) (Xing et al., 2000). The number of plaques obtained in the
presence of receptor molecules was compared to the amount of plaques observed in
the absence of receptor.
Antibody blocking assay and immunoperoxidase staining. The confluent SAOS-
α2β1 were preincubated with different antibodies or their combinations for 15 min at
RT: anti-α2 integrin (12F1; BD Pharmingen), anti-β2 microglobulin (polyclonal
rabbit antibody AB730; Chemicon and monoclonal antibody BM-63; Sigma) and anti
human HLA-I W6/32 (Barnstable et al., 1978). After 10 h incubation at 37°C with
EV1, the cells were fixed with methanol and stained with anti-EV1 rabbit antiserum
and horseradish peroxidase-conjugated swine anti-rabbit immunoglobulin (Dako,
Denmark) (Ziegler et al. 1988).
Cell binding assay. SAOS-pAW or SAOS-α2β1 cells, suspended into PBS
containing 1 mM MgCl2 (PBS-MgCl2) were incubated with [35S]-labelled EV1 for 1
h on ice. The cells were washed with PBS-MgCl2 and analysed for radioactivity in a
scintillation counter.
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4. Sucrose gradient sedimentation (I-III)
To study whether the binding of EV1 to GST-α2I domain can trigger conformational
changes in the viral capsid, [35S]-labelled EV1 was incubated with 100-1000 nM α2I-
GST for different time periods at 4°C and at 37°C. To investigate the uncoating of the
virus during the entry into host cells, [35S]-labelled virus was allowed to bind to
detached SAOS-α2β1 or GMK cells in suspension for 1 h at 4°C prior to incubation
of 30 min-2 h at 37°C. The cells were lysed with 1% Triton-X-100 for 10 min on ice.
The collected samples were centrifuged in a linear 5-20 % sucrose gradient and the
radioactivity of collected fractions was measured in a scintillation counter.
5. Immunofluorescence microscopy (I-III)
After the binding of viruses to the cells in cold for 1 h and the infection at 37°C for an
appropriate time, the cells were fixed with 4% formaldehyde or 4% paraformaldehyde
(Sigma), quenched with 50 mM NH4Cl and permeabilized with 0.05% (w/v) saponin
(Sigma) or 0.3% Triton-X-100 (Sigma) in PBS. The primary antibodies described in
Table 3 were used for immunofluorescent labelling (Table 3). To recognize the
primary antibodies, we used AF-488- and 568–conjugated anti-mouse, anti-goat and
anti-rabbit secondary antibodies (Molecular Probes). Mouse anti-HA antibody
(BabCO) was used to recognize the HA-tag.
AF-488-conjugated cholera toxin subunit B (0.5 or 10 µg/ml; Molecular Probes) was
used in the EV1 internalization studies as a marker of the caveolar route. Lysotracker
Red DND99 (100 nM) (Molecular Probes) was used to mark the lysosomes and holo-
transferrin (1 mg/ml; Sigma) to detect the clathrin route. The labelled molecules were
either preincubated with cells prior to virus infection or added simultaneously with
the virus.
After staining with primary and secondary antibodies, the cells were mounted for
microscopy. Microscopy was performed either with an Axiovert confocal microscope
(Leica TCS SP2) with an HCX PL APO 63x/1.32-0.6 oil objective or with Axiovert
100 M SP epifluorescence microscope (Carl Zeiss, Jena, Germany) equipped with a
confocal setup (Zeiss LSM510), using a Plan Neofluar objective (63x/1.25 oil). For
quantification of infection percentages, images of 100-200 cells were taken with an
Olympus BX50 immunofluorescence microscope containing a CCD camera
(Hamamatsu), using a U Plan FI 20X/0.5 Ph1 objective and the Open Lab 2.2.5
program (Improvision). Further analysis of the results is explained in the
corresponding articles (I-III).
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6. Real-time fluorescence microscopy (III)
After binding of AF-EV1 to untransfected or GFP-tagged caveolin-1-transfected CV-
1 cells for 1 h at 4°C, the microscopy was performed at 37°C using a Zeiss Axiovert
wide-field microscope with a 100 X NA 1.4 plan-apochromat lens, a computer-
controlled shutter and standard FITC/Alexa Fluor-594 filters. Images were collected
with a CCD camera, with 2×binning, delay times of 4-10 s and exposure times of 0.5-
1 s/image. The collected images were further processed using Open Lab 2.2.5
software.
Table 3. Primary antibodies used for immunofluorescence microscopy.
Target of
detection
Antibody Manufacturer/Reference
Capsid proteins
of EV1
- polyclonal rabbit antiserum
against EV1
(Marjomäki et al., 2002)
integrin α2
subunit
- MAb 12F1
- MAb 1950
- AF-488-labelled mouse antibody
MCA2025
- rabbit antiserum
BD Pharmingen
Chemicon
Serotec
Transduction laboratories
integrin α2I
domain
- anti-CD49b monoclonal antibody Immunotech
Caveolin-1 - polyclonal rabbit antibody
- rabbit antibody N-20
- MAb 2234
- MAb
Transduction Laboratories
Santa Cruz Biotechnology
Transduction Laboratories
Zymed
Myc-tagged
transferrin
receptor chimera
- MAb against myc-peptide ATCC
Clathrin route - rabbit anti-transferrin antibody Behring Institute
Early endosomes - polyclonal antiserum against
EEA1
(Mu et al., 1995)
Late endosomes - polyclonal antiserum against the
cation-independent mannose-6-
phosphate receptor (CI-MPR)
(Marjomäki et al., 1990)
Lysosomes - MAb for CD63 Zymed
Trans-Golgi
network
- MAb anti-p230
- polyclonal rabbit antiserum GB2
- TGN-46
Transduction Laboratories
(Banting et al., 1998)
Cis-Golgi
network
- polyclonal antiserum against p23 (Rojo et al., 1997)
ER - MAb against PDI (ID3) from S. Fuller, University of
Oxford, United Kingdom
sER - goat antibody against syntaxin 17 (Steegmaier et al., 1998)
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7. Fluorescence in situ hybridisation (III)
The negative-polarity RNA strand was transcribed using SP6 polymerase (Promega)
from linearized EV1 cDNA (full-length EV1 cDNA in the pSPORT1 vector) (Ohman
et al., 2001) in the presence of FITC-labelled UTP (Molecular Probes) or Chromatide
Alexa Fluor-546-14-UTP (Molecular Probes). After DNase I treatment, the probe was
purified as described earlier (Bolten et al., 1998). To perform fluorescence in situ
hybridisation (FISH), the untransfected and GFP-caveolin-1 -transfected CV-1 cells
were infected with EV1 and the hybridisation reaction was performed in the presence
of the labelled probe for 12 h at 42°C in the dark (Bolten et al., 1998). After removal
of the unbound probe, cells were mounted with 2.5% DABCO (Sigma) in pH-
buffered glycerol and visualized using a confocal microscope (Leica) as described
above.
8. Protein synthesis assay (IV)
For the analysis of host cell protein synthesis during infection, the cells were infected
with purified viruses (EV1, CBV4, PV1) and incubated at 37°C until most of the cells
showed CPE. After starving of cells in the presence of MEM-met (Gibco) for 30 min,
they were labelled with 50 µCi/ml of [35S]methionine (Amersham). The cells were
either harvested directly after a pulse labeling for 15 min or chased in complete
medium (MEM) for additional 30 min at 37°C. The radioactively labelled proteins
were analysed in 12% SDS-PAGE.
9. cDNA array technique (IV)
To study the effects of enterovirus infection on cellular gene expression, HOS
pα2AW cells were infected with purified EV1 (MOI 130 corresponding to 0.5 µg of
purified virus/1x106 cells). HeLa-Ohio cells were infected either with purified CBV4
or PV1 (MOI 20). The infected and mock-treated control cells were collected after
different time intervals. Total cellular RNA was purified using the thiocyanate-CsCl
method (Chirgwin et al., 1979). Five µg of total RNA was converted to specific 32P-
labeled cDNA species by using MMLV reverse transcriptase (Clontech), in the
presence of CDS primer mix (Clontech) and 10 mCi/ml of [α32P]dATP (Amersham).
Equal amounts of 32P-labeled cDNA as cpm values from infected and uninfected cells
were hybridised to two identical filters, using both Atlas human cDNA array and
Atlas human cDNA 1.2 array (Clontech) according to the manufacturer’s instructions.
The filters were exposed on BioMAX MS film (Kodak) and phosphoimager screen
(Fuji). The photo-stimulated luminescence (PSL) -signals were measured by using
phosphoimager MacBas -quantitation program (Fuji).
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RESULTS AND DISCUSSION
1. Cell surface interactions of echovirus 1 (I-III)
1.1 α2β1 integrin as EV1 receptor (I-III)
To study the attachment of EV1 to the cell surface, the radioactively labelled
virus was allowed to bind to control SAOS-pAW cells, lacking the integrin
α2 subunit and to SAOS-α2β1 cells, which have been transfected with a
vector carrying the α2 subunit (Ivaska et al., 1999b). The binding assay
revealed that over 70% of virus particles were able to bind to SAOS-α2β1
cells whereas only 0.5% of particles were bound to SAOS-pAW cells (II, Fig.
2B; The figures referring to original publications are marked in italics). Only
SAOS-α2β1 cells were susceptible to EV1 infection, which was efficiently
inhibited (86%) by antibodies against α2 integrin in a immunoperoxidase
staining assay (II, Fig. 1 and 2A, C, D). In confocal studies of the infected
cells, the virus and the integrin colocalized on the cell surface immediately
after virus attachment on ice (0 h p.i.) (II, Fig. 4A). The α2β1 integrin also
colocalized with EV1 in the perinuclear accumulations after incubation at
37°C (II, Fig. 4A, III, Fig. 2C), indicating that the integrin plays also a role in
the internalization of the virus. In addition, the preincubation of EV1 with
integrin α2I domain-GST (α2I-GST) prior to addition of the virus to cells
blocked infection in a dose-dependent manner (I, Fig. 1A).
Overall, our results, in accordance to earlier reports (Bergelson et al., 1992),
showed that α2β1 integrin may be sufficient for EV1 attachment and cell
entry. However, the role of accessory receptors in EV1 entry cannot yet be
excluded. In our investigations, the antibodies against β2 microglobulin
(β2m) caused an efficient inhibition (95%) of EV1 infection in SAOS-α2β1
cells (II, Fig. 2D). Although β2m is coexpressed with MHC class I molecule
on the cell surface, the antibodies tested against MHC class I did not inhibit
infection. In immunofluorescence confocal microscopy studies, β2m was not
internalized into cells together with the virus and the integrin (II, Fig. 4B).
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Because antibodies against β2m have been reported to block the infection of
several enteroviruses (Ward et al., 1998), the molecule may be unspecifically
involved in the virus life cycle. Alternatively, antibodies against β2m may
cause a steric hindrance to viral binding to other receptors.
1.2 The α2I domain binds to the EV1 canyon (I)
The tools for structural studies of EV1-α2I domain interaction became
available when the structure of α2I domain was solved in 1997 (Emsley et al.,
1997), and the atomic structure of EV1 was visualised by x-ray
crystallography in 1998 (Filman  et al., 1998). In our study, cryo-EM
reconstruction was used to illustrate the structural interactions of EV1 with
α2I-GST fusion protein (I).
Figure 9. A) The α2I domain (gray; fitted into the difference density map) interacts
with two adjacent protomers of EV1 capsid. 5-fold and 3-fold axes are indicated. B)
The charged residues important for EV1-α2I domain interaction, including Lys201,
Asp219 and Arg288 in the I domain and Glu2162, Asp2163, Lys3230 and Glu1273 in
the virus are indicated. (Adapted from the original publication IV, Fig. 2 C, D).
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Residues involved in α2Ι  domain-EV1 interaction. The reconstruction of
EV1-α2I domain revealed that the virus is decorated by 60 copies of α2I
domain (I, Fig. 2B). α2I located roughly between the viral 2-fold and 5-fold
axis. The unliganded α2I domain structure (Emsley et al., 1997) was fitted
into the difference density map, generated by subtracting the crystal structure
based density of native EV1 (I, Fig. 2A) from the cryo-EM density map of the
virus-receptor complex (I, Fig. 2B). In the resulting model, both the N- and C-
termini of the I domain pointed outwards from the virus-interacting face (Fig.
9A), thus resembling the natural situation where these termini ends are
connected with a β-propeller structure of the α2-subunit.
The binding site of the α2I domain in the EV1 surface is situated mostly on
the outer (=south) wall of the viral canyon (Fig. 9A). Instead, the I domain is
not in intimate contact with the inner (=north) canyon wall. The α3 helix of
the α2I domain together with the connecting loops interact with the VP2 from
one protomer and the globular head contacts VP3 from a neighbouring
protomer of EV1 (Table 4, Fig. 9A).
Table 4. The interacting residues in α2I domain and EV1. The viral proteins and
residues involved in the interactions have been resolved in the cryo-EM study of α2I -
EV1 complex (I).
STUDY METHOD α2I RESIDUES EV1 PROTEINS EV1 RESIDUES
- Cryo-EM reconstruction
- Chimeras of human and
mouse α2I (King et al.,
1997)
- Tyr200, Lys201
- 199-201
between C-strand
and α helix 3
E-F loop of VP2
Glu2162
Asp2163
His2164
- Cryo-EM reconstruction
- Chimeras of human and
mouse α2I (King et al.,
1997)
- Tyr216
- 212-216
bw. α helix 3 and
α helix 4
above the interface
of two adjacent
protomers
Tyr216 of α2I
points toward the
viral surface
- Cryo-EM reconstruction Asp219 VP3 Lys3230
- Cryo-EM reconstruction Arg288 in
αC-α6 loop
the C-terminus of
VP1 of the 2nd
protomer
Glu1273
- Chimeras of human α1I
and human α2I (Dickeson
et al., 1999)
Arg289 in αC-α6
loop
the C-terminus of
VP1 of the 2nd
protomer
No direct contact,
conformational
effect possible
Results and Discussion
57
The MIDAS points towards the canyon floor but it is not in close contact with
the virus. The charged residues (Lys201, Asp219 and Arg288) of α2I domain
interact most probably with viral residues Glu2162-Asp2163, Lys3230, and
Glu1273 (numbered to start as 1001 for VP1, 2001 for VP2, 3001 for VP3
and 4001 for VP4) (Fig. 9B). The earlier studies with a mutated integrin α2
subunit and with integrin chimeras have shown that the amino acids in regions
199-201 and 212-216 (King et al., 1997) as well as Arg289 (Dickeson et al.,
1999) in α2I domain interact with the virus. Most of the corresponding
residues are in contact with the virus according to our cryo-EM reconstruction
of EV1-α2I domain complex, as shown in Table 4.
Like α2β1 integrin, the IgSF receptors of major group HRVs, PVs, and CBV3
bind to the viral canyon (He et al., 2001). In contrast, non-IgSF receptors, like
LDLR (minor group of HRVs) and DAF (EV7) bind outside the canyon
(Hewat et al., 2000; He et al., 2002). When compared to PVR-PV interaction
(Xing et al., 2000), both ICAM-1 (Olson et al., 1993; Xing et al., 2000) and
the α2I domain are oriented deeper towards the canyon floor and the pocket
factor cavity of the viruses. Both ICAM-1 (Olson et al., 1993) and the α2I
domain primarily interact with the outer wall of the canyon. In contrast, the
PVR has been argued to contact either both the outer and inner walls (Belnap
et al., 2000b; He et al., 2003) or predominantly the outer wall of PV (Xing et
al., 2000). Whatever the case, the α2I domain makes more extensive contacts
with the outer canyon wall than ICAM-1 or PVR. Moreover, compared to
footprints of ICAM-1/PVR on the major group HRVs/PVs, the footprint of
the α2I domain on EV1 is more globular.
Structural data on other picornavirus-integrin interactions are not yet
available. These interactions may anyhow differ significantly from EV1-α2β1
integrin interactions, since they occur through the viral RGD sequence (Chang
et al., 1989; Fox et al., 1989; Hyypiä et al., 1992), not present in EV1 capsid.
Moreover, αv integrins do not carry the αI domain. Instead, the I-like domain
of β-subunit is involved in the integrin interactions with the RGD motif
(Xiong et al., 2002).
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1.3 The differences in interactions of α2β1 integrin with EV1 and
collagen (I)
In our study, a crystal structure of collagen-like triple helical peptide bound
on the α2I domain (Emsley et al., 2000) was superimposed into the model of
EV1-α2I domain (I, Fig. 3A, B). Extensive overlap between collagen and the
virus was observed, indicating that these two ligands could not bind the
integrin simultaneously even though their binding sites in the α2I domain are
distinct, as also shown in other studies (Kamata et al., 1994; King et al.,
1997). The MIDAS site, known to interact with the middle strand of collagen
(Emsley et al., 1997; Emsley et al., 2000), is not involved in EV1-α2β1
interaction as demonstrated here and elsewhere (Bergelson et al., 1993a; King
et al., 1997). In the cryo-EM model of EV1-α2I, the MIDAS site points
towards the canyon floor of EV1 and thus it is inaccessible for simultaneous
collagen binding. However, there is enough space to simultaneously
accommodate another MIDAS-binding element, a cyclic RKKH -containing
octapeptide (Ivaska et al., 1999a). The peptide has been shown to block
collagen binding to the α2I domain but to increase EV1 binding, most
probably by increasing the contact surface between the I domain and virus
and by shielding the negatively charged residues of the MIDAS.
Adhesion of collagen to α2β1 can be abolished by chimeras containing the
cytoplasmic domains of other integrin subunits in place of α2 tail (Kawaguchi
and Hemler, 1993). However, the virus could infect chimeric SAOS-α2/α1β1
cells (II, Fig. 2). Therefore, the α2 cytoplasmic domain is not required for
EV1 entry or infection, in line with the earlier results (Bergelson et al.,
1993a). Further studies should be performed to find out whether the
cytoplasmic domain of β1 integrin subunit, instead of the α2 tail, could play a
role in signalling events related to EV1 endocytosis (Upla et al., 2004).
The buried surface area of I domain was much larger (850Å) when bound to
EV1 compared with collagen-like peptide (359Å), indicating that the affinity
of virus to the I domain could be higher than that of collagen (I). The binding
affinity of EV1 to the I domain, measured by solid phase binding assay, was
found to be about 10 times higher when compared with type I collagen (I,
Fig. 3C). Thus, in tissue, the virus has either to compete with collagen on
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binding to α2β1 integrin or find ligand-free integrin molecules. Normally,
α2β1 integrin is expressed on basolateral surface of cells, where it is occupied
by collagen or other natural ligands. However, in some cell types, such as in
keratinocytes, the integrin may be expressed on free from natural ligands
(Larjava et al., 1993) and thus it may be more susceptible to virus infection.
1.4 EV1 binding to α2β1 integrin may trigger integrin clustering (I)
The confocal studies of α2β1 integrin showed the formation of integrin
clusters on the cell surface after the virus attachment and a similar clustering
was induced by cross-linking the integrin molecules with antibodies (I, Fig.
4). To study whether EV1 could bind many integrin molecules
simultaneously, a model of α2β1 heterodimer was constructed based on the
crystal structures of extracellular parts of αvβ3 (Xiong et al., 2001) and α2I
domain (Emsley et al., 1997). The model was then superimposed on α2I
domain - EV1 structure. As a result, five copies of the integrin molecule were
found to bind without steric hindrance around the viral five-fold axis, possibly
resulting in integrin clustering (I, Fig. 5). This is in accordance with other
findings suggesting that the attachment of EV1 to α2β1 integrin can induce
the clustering of integrin molecules, which in turn leads to signalling events,
required for endocytosis of EV1 (III, Upla et al., 2004). Interestingly, binding
of adenovirus to the αvβ5 integrin may lead to similar clustering of integrin
molecules (Chiu et al., 1999), which is followed by signalling events essential
for virus entry into host cells (Greber, 2002).
1.5 The uncoating of EV1 is not triggered by cell surface
interactions (I-III)
To identify whether the cell surface interactions of EV1 are able to trigger the
uncoating of the virus, EV1 was incubated alone, with the α2I-GST or with
GMK or SAOS-α2β1 cells and the conformational alterations of the virus
were measured by sucrose gradient centrifugation. At 4°C, the viral capsid
was observed in 160S form of intact virus that carries the genome (I, Fig. 1B).
Incubation of EV1 at 37°C for 1 h induced a spontaneous uncoating of the
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virus, leading to the formation of 80S empty particles (I, Fig. 1B). However,
the incubation of EV1 with α2I-GST at 4°C, 20°C and 37°C for different time
periods caused only minor changes in virus sedimentation and did not lead to
formation of 135S or 80S particles (I, Fig. 1B).
It could be speculated that the binding of the entire α2β1 to EV could bring
about different actions other than the α2I-GST alone or that some other cell
surface molecules could induce the conformational changes of EV1 particle.
However, only minor alterations in virus sedimentation, somewhat similar to
those observed in the presence of the α2I domain, were observed after
binding of EV1 onto cell surface at 4°C (II, Fig. 3A, III, Fig. 8A). When
compared to control 135S particles of PV, the altered EV1 particles
sedimented again much closer to the 160S peak. The studies with mutant PVs
have revealed another intermediate of viral entry, the 147S particle, which
may sediment close to 160S particle and which may be much less stable than
135S (Pelletier et al., 2003). Therefore, further investigations are required to
clarify the nature of altered EV1 particles. On the other hand, the minor
changes observed in virus sedimentation could be due to the formation of the
EV1-α2I domain/integrin complex.
Our results suggest that cell surface interactions of EV1 do not lead to the
instant uncoating of the virus on the cell membrane, even though the slight
alterations may be caused in the virion. Moreover, the α2I domain may
stabilize EV1 structure in vitro, or at least inhibit the formation of 80S empty
particles. This is different from many other picornavirus-receptor interactions,
such as PV-PVR and HRV-ICAM-1, which lead to obvious conformational
changes in the viral capsid and formation of 135S particles. Finally, these
interactions may result in the formation of 80S particles and release of
genomic RNA during the incubation at 37°C (Xing et al., 2000). The
stabilization of EV1 capsid by α2I domain might ensure that the virus is
endocytosed to the location adjacent to the replication site before the release
of viral genome is triggered by intracellular factors.
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2. The endocytosis of echovirus 1 into caveosomes (II, III)
Because integrins are known to mediate the internalization of several
pathogens, it was of interest, whether the α2β1 integrin could guide EV1 into
a specific endocytic route (II, III). To study the uptake of EV1 into host cells,
both microscopic methods (e.g. EM, immunofluorescence microscopy and
real-time microscopy) and biochemical and virological approaches (e.g.
fluorescence in situ hybridisation (FISH), infectivity assays and sucrose
gradient centrifugation) were applied. SAOS-α2β1 cells were used in studies
of EV1 endocytosis because they overexpress the α2β1 integrin. Thus, the
visualization of the integrin in this particular cell line is facilitated in
fluorescence microscopy. CV-1 cells were primarily chosen because of their
excellence in real-time live microscopy studies, and because the caveolar
endocytosis of SV40 has been well-characterized in this particular cell line.
The infectious cycle of EV1, detected by infection titration, took
approximately 6-8 h in these cell lines (II, Fig. 2E, III, Fig. 1B). The genomic
viral RNA, detected by FISH technique, was observed to increase at 4 h p.i. in
CV-1 cells (III, Fig. 8C). The increase indicated the synthesis of new viral
RNA and thus suggested that viral replication takes place at 3-4 h p.i.
2.1 EV1 does not utilize clathrin-mediated endocytosis (II, III)
In double-labelling immunofluorescence microscopy, EV1 colocalized with
the α2β1 integrin on the cell surface (II, Fig. 4). Soon after binding, already
at 5 min p.i., the virus started to internalize together with the integrin into the
host cells. Even though receptor-mediated uptake is a typical characteristic of
clathrin-mediated endocytosis, the virus or its receptor were not found in
organelles of the clathrin route, such as EEs, recycling endosomes or LEs by
immunofluorescence microscopy (II, Fig. 5). When the formation of clathrin-
coated vesicles was prevented by expression of Eps15E∆95/295-GFP
(Benmerah et al., 1999), no inhibition of EV1 infection was observed in CV-1
or SAOS-α2β1 cells (III). Overexpression of AP180C, which interferes with
the clathrin route and uptake of HRV2 (Ford et al., 2001; Snyers et al., 2003)
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did not exert this inhibitory effect either. Accordingly, the same constructs
have revealed no effect on the internalization of the α2β1 integrin after
antibody-crosslinking (Upla et al., 2004).
The clathrin route of entry is utilized among picornaviruses, for instance, by
minor group HRVs, which take advantage of endosomal acidification for
uncoating (Bayer  et al., 1998). Instead, enteroviruses, like EV1, are
distinguished from other picornaviruses by their acid stability and may thus
have different requirements for the milieu of uncoating. Moreover, the
specific location of viral receptor on the cell surface may influence the
selection of endocytosis route. For example, acid-stable EV11 binds to a
receptor (DAF) located in lipid rafts, and then enters the cells via lipid
raft/caveolae-mediated endocytosis (Stuart et al., 2002a). Interestingly,
integrins can also be associated with lipid rafts (Upla et al., 2004) and
caveolae (Wary et al., 1998).
2.2 EV1 may utilize both cell surface caveolae and an alternative
pathway to enter host cells (II, III)
Endocytosis via caveolae. The EM of EV1-infected SAOS-α2β1 cells
demonstrated the localization of the virus in caveolae-like invaginations on
the cell surface (II, Fig. 6B). More detailed studies on location of the viral
receptor, α2β1 integrin, have suggested that the integrin is first associated
with raft-like membrane microdomains, from where it is laterally distributed
to cell surface caveolae upon EV1 binding (Upla et al., 2004). In fact, both α
and β subunits of α2β1 integrin can also associate with caveolin-1, the main
protein component of caveolae (Wei et al., 1996; Wary et al., 1998).
Several known inhibitors of caveolar internalization and dominant negative
mutants of the pathway were able to prevent EV1 uptake and/or infection (II,
Table 1, III, Fig. 3). Expression of dominant negative caveolin-3DGV, which
inhibits SV40 infectivity by 40% (Roy et al., 1999), diminished EV1 infection
by 35% in CV1 cells and by 66% in SAOS-α2β1 cells. Caveolin-3DGV
disrupts lipid transport and causes depletion of lipid rafts, thus inhibiting
caveolar endocytosis (Roy et al., 1999). The dominant-negative mutant of
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dynamin 2 (K44A), which prevents the caveolar and clathrin-coated pit
internalization (Damke et al., 1994; Henley et al., 1998; Oh et al., 1998),
inhibited EV1 infection by 75% in CV-1 cells. Moreover, drugs interfering
with the composition of lipid rafts and caveolae and with the cholesterol
distribution (methyl β-cyclodextrin, progesterone and nystatin) hindered EV1
infection. In addition, methyl β-cyclodextrin decreased the intracellular
colocalization of the virus, caveolin-1 and the integrin by over 90% in SAOS-
α2β1 cells.
Tyrosine kinase activation is essential for the EV1 replication cycle since the
infection was blocked by a tyrosine kinase inhibitor, genistein, in a dose-
dependent manner in CV-1 cells. Genistein is known to inhibit the caveolar
uptake of several other ligands, including AMF, CTX and SV40 (Dangoria et
al., 1996; Le and Nabi, 2003). Furthermore, bisindolylmaleimide, a specific
inhibitor of protein kinase Cα (PKCα), prevented EV1 infection in CV-1 cells
(III, Fig.6). PKCα activation has also been demonstrated in EV1-infected
SAOS-α2β1 cells, where it triggers viral entry and leads to activation of ERK
(Upla et al., 2004). Interestingly, PKCα is known to bind to the cytoplasmic
domain of the β1 integrin subunit and to regulate cell motility (Ng et al.,
1999). Our results are also in line with the fact that caveolae-enriched PKCα
(Mineo et al., 1998) is required for stimulation of caveolar internalization
(Sharma et al., 2004).
Taken together, the results suggested that EV1 particles may utilize dynamin-
dependent uptake via cell surface caveolae and that the uptake requires
particular signalling events.
An alternative route of endocytosis. A number of findings suggested that
EV1 might, in addition to uptake via cell surface caveolae, use an alternative
pathway for endocytosis. When endocytosis of fluorescently labelled EV1
was followed into GFP-caveolin-1 transfected CV-1 cells by real-time live
microscopy, the majority of EV1 particles did not colocalize with GFP-
caveolin-1 at the very beginning of infection (III). Dominant-negative GFP-
construct of caveolin-1, in which the N-terminal domain is truncated
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(caveolin-1-GFP), did not inhibit EV1 internalization or infectivity in CV-1 or
SAOS-α2β1 cells (III), even though it has been reported to prevent the
uptake of SV40 through caveolae (Pelkmans et al., 2001). Our results
indicated that either the N-terminus of caveolin-1 is not required for
interactions EV1 in cell surface caveolae or the virus utilizes a different
uptake mechanism than SV40 in CV-1 cells.
For further evidence of an alternative pathway, some inhibitors, described to
affect caveolar internalization, had unexpected effects on the EV1 infectious
cycle (III, Fig. 6B). Such inhibitors included okadaic acid (an inhibitor of
serine and threonine phosphatases), which should increase caveolar
internalization (Parton et al., 1994) and sodium orthovanadate (an inhibitor of
protein tyrosine phosphatases) that enhances the uptake of SV40 via caveolae
(Pelkmans et al., 2002). Unexpectedly, okadaic acid did not significantly
affect EV1 infection and sodium orthovanadate reduced the viral infectivity
by 70%. However, the effects of these drugs were tested on EV1 infectivity
and not specifically on virus internalization. Therefore, they may also disturb
later steps of EV1 infection. The actin-disturbing agents, such as latrunculin
A, cytochalasin D and jasplakinolide, did not interfere with EV1 infection in
CV-1 cells (III, Fig. 6C), again opposite from the fact that internalization of
ligands through cell surface caveolae requires cortical actin (Parton et al.,
1994; Pelkmans et al., 2002). In contrast, in SAOS-α2β1 cells, the actin
polymer-stabilizing drug jasplakinolide caused the maintenance of virus and
the integrin on the cell membrane and inhibited infection.
The results suggested that depending on the cell line and cellular
environment, EV1 can switch from caveolar pathway to another
internalization pathway. This could occur, for instance, when the function of
plasmamembrane caveolae is inhibited. This hypothesis is in line with recent
studies, which have revealed that alternative pathways of entry are utilized by
other viruses and bacterial toxins (Damm et al., 2005; Kirkham et al., 2005).
Whilst our findings favour the model that the non-caveolar cell surface lipid
rafts are involved in the uptake of EV1 via an alternative pathway, further
investigations are required to establish their role in EV1 entry.
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2.3 EV1 is internalized into caveosomes (II, III)
The immunolabelling of cryosections from EV1-infected cells showed the
colocalization of the virus and caveolin-1 in uncoated, intracellular vesicles of
60-90 nm (II, Fig. 6C, E). These structures were immunoisolated from the
infected cells with beads coated with caveolin-1 antibody that recognizes
caveolin-1 only in intact vesicle structures (Oh and Schnitzer, 1999) (II, Fig.
8). Based on immunisolation, the virus and α2β1 integrin were detected in the
caveolin-1 -positive fractions in significantly increased amounts at 15 min p.i.
Live microscopy of CV-1 cells, transfected with GFP-tagged caveolin-1 and
infected with the fluorescently labelled EV1, revealed a dramatic increase in
the colocalization of the virus and caveolin-1 after 10 min p.i. (III).
Approximately at 20-30 min p.i., the larger clusters of caveolar vesicles were
observed in the electron micrographs of EV1-infected SAOS-α2β1 cells (II)
and in the real-time microscopy of CV-1 cells (III). The majority of these
organelles were mobile, and they preformed random, short (3-6 µm) or
medium distance (9-14 µm) movements with velocities of 0.02-0.3 µm/s. A
continuous sorting of virus particles between the vesicles was observed. The
behaviour and the outlook of the vesicles detected with live microscopy were
similar to caveosomes, organelles involved in SV40 uptake (Pelkmans et al.,
2001) and cholera toxin (CTX) (Montesano et al., 1982; Nichols, 2002).
Therefore, the colocalization of EV1 with these markers of caveosomal route
was investigated.
EV1 colocalizes partially with CTX and SV40 in caveosomes.
Fluorescently labelled CTX colocalized partially with EV1 at 30-60 min p.i.
in intracellular vesicular structures, distributed throughout the cytoplasm.
After 1 h p.i., CTX had accumulated into the Golgi complex, without an
apparent colocalization with EV1 capsid proteins (III, Fig. 4A). However,
CTX is not an accurate marker of caveosomes, because it can also traffic from
caveolar vesicles directly into EEs of the clathrin-coated pathway (Pelkmans
et al., 2004), or it may even enter via non-clathrin, non-caveolar endocytosis
(Kirkham et al., 2005). In the light of these reports, further studies are
required to specify the organelles where EV1 and CTX meet. However, based
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on our other findings listed here, the organelles seem to represent
caveosomes.
The entry of SV40 and EV1 to coinfected CV-1 cells was followed in real-
time live microscopy and by immunofluorescence confocal microscopy (III,
Fig. 5A, B). The partial colocalization of EV1 with SV40 in small, fairly
immobile structures was observed at 15-30 min after EV1 entry. Upon
infection, the colocalization of the viruses as well as the size and the mobility
of organelles, where they colocalized, increased. To artificially accumulate
the majority of SV40 particles into caveosomes, CV-1 cells were treated with
nocodazole, a microtubule-disrupting agent that does not affect the uptake of
SV40 into caveosomes but inhibits its traffic to the ER (Pelkmans et al., 2001)
(III, Fig. 5C). The drug treatment resulted in an increased colocalization of
SV40 and EV1, again supporting the hypothesis that EV1 is transported into
caveosomes.
Brefeldin A (BFA), a widely used inhibitor that disrupts the Golgi and also
inhibits the different steps of caveolar endocytosis of SV40 and polyomavirus
(Norkin et al., 2002; Richards et al., 2002) inhibited EV1 infection most
effectively when added before 3 h p.i. (III, Fig. 7A). In the presence of BFA,
both EV1 and SV40 accumulated in coinfected cells into large, caveolin-1 -
positive organelles (III, Fig. 7B) that showed no staining with endosomal (CI-
MPR) or lysosomal (CD63) markers. Based on our results, the drug may
cause the accumulation of EV1 into caveosomes by preventing the uncoating
of EV1, or the release of EV1 from caveosomes by stabilizing the caveosomal
membranes. Moreover, BFA may inhibit the viral RNA replication, as in the
case of another enterovirus, PV (Maynell et al., 1992).
These findings indicate that the caveolin-1 -positive structures in which EV1
was transported from the cell surface together with its receptor, α2β1 integrin,
are caveosomes. The uptake of both SV40 (Pelkmans et al., 2001; Pelkmans
et al., 2002; Damm et al., 2005) and EV1 into caveosomes appears to be
caveolae/non-caveolar lipid raft -derived, tyrosine kinase -dependent and
largely by-passes endosomes and lysosomes (Figure 10). However, the
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detailed endocytic mechanisms of these viruses differ in many aspects,
highlighting distinct roles of caveosomal route in virus infections.
Figure 10. The proposed internalization routes of EV1 and SV40 into caveosomes. In
addition to "classical" caveolae-mediated endocytosis, SV40 can enter the
caveosomes via more rapid alternative pathway, which is dependent on noncaveolar
lipid rafts (Damm et al., 2005). (Modified from Pietiäinen et al., submitted).
2.4 EV1 remains in caveosomes prior to replication (III)
To investigate whether EV1 capsid proteins are transported to the ER or to the
Golgi complex, several antibodies were used to mark these organelles in
immunofluorescence microscopy of the infected cells (II, Fig. 5, III, Fig. 4B).
However, the viral proteins did not colocalize with any tested markers for the
smooth and rough ER or the trans- or cis-Golgi networks in SAOS-α2β1 cells
at 2 h p.i (II, III). In CV-1 cells, EV1 was not detected in the trans-Golgi nor
in the ER at 2-4 h p.i (III). Based on these results, we concluded that EV1
capsid proteins do not enter the ER or the Golgi complex, but may remain in
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caveosomes. This is in contrast to SV40 and polyomavirus, which are carried
from caveosomes into the (s)ER in a microtubule-dependent manner
(Pelkmans et al., 2001; Gilbert and Benjamin, 2004). Instead, the traffic of
ligands from the cell surface to caveosomes does not always require
microtubules (Pelkmans and Helenius, 2003).
The transport of some caveosomal vesicles carrying fluorescently labelled
EV1 seemed very similar to microtubular transport when followed in real-
time microscopy. However, the disruption of microtubules by nocodazole did
not apparently affect EV1 distribution or infectivity, detected by
immunofluorescence confocal microscopy (III). Most probably, viral proteins
can utilize microtubules for trafficking within the host cell, but these are not
obligatory for the infectious cycle, since the virus may not need to be
transported further from caveosomes.
The sucrose gradient analysis of conformational changes of EV1, after
incubation of the radioactively labelled EV1 with SAOS-α2β1 and GMK
cells for 30 min-2 h at 37°C, suggested that disassembly of the virus may
occur after it has been endocytosed (II, Fig. 3B, III, Fig. 8B). This was in
accordance with the results obtained with FISH technique, where a probe
recognizing a positive-stranded, genomic viral RNA was hybridised into EV1
-infected, GFP-caveolin-1 -transfected CV-1 cells (III, Fig. 9B). At the
beginning of the infection, the viral RNA did not clearly colocalize with
caveolin-1. However, at the time of the uncoating (1-2 h p.i.) the viral RNA
colocalized mostly with EV1 capsid proteins in caveosomes, and the capsid
proteins were not found in any other cellular compartments at 1-4 h p.i.
These results may indicate that the virus resides within caveosomes until
uncoating and replication take place, the phenomenon not observed with any
other ligands of caveosomal route. Therefore, it would be of great interest to
investigate the release mechanisms of EV1 and/or viral RNA from
caveosomes.
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3. Echovirus 1 infection results in alterations of host cell gene
expression (IV)
The previous studies on cellular effects of EV1 have focused on individual
genes and their activation by MAP kinase pathways (Huttunen et al., 1997;
Huttunen et al., 1998). The availability of novel cDNA array technology
encouraged us to undertake a broad screening of the host cell gene
transcription profile during EV1 infection (IV). cDNA copies of cellular
mRNAs were isolated from uninfected and infected cells and hybridised onto
cDNA arrays. The human cDNA arrays contained either 588 genes (assayed
for EV1 -infected cells at 1, 3, 6, and 10 h p.i.) or an additional 588 genes
(assayed for EV1 -infected cells at 10 h p.i.). HOS-pα2AW cell line was
selected for the experiments because the cell line has been used in previous
studies of EV1-induced host cell gene regulation (Huttunen et al., 1997;
Huttunen et al., 1998).
At earlier time points of EV1 infection (1, 3, 6 h p.i.), no significant
alterations (i.e. over 2-fold) of host cell gene expression were observed (IV).
At 10 h p.i., the virus production in HOS-pα2AW cells had reached its
maximum. When the samples from 10 h p.i were screened with cDNA arrays
containing 1176 genes, only 2% of sequences were found to have a significant
(2-fold) increase in expression. Meanwhile, less than 0.5% of investigated
host cell genes were downregulated during EV1 infection. Such a low amount
of downregulated genes was somewhat unexpected, because enteroviruses, at
least PVs, should be able to inhibit cellular RNA synthesis (Rubinstein and
Dasgupta, 1989). On the other hand, many cellular genes are preferentially
upregulated during virus infections (Jenner and Young, 2005). The products
of the activated genes were involved in cellular signalling events, apoptotic-
and antiapoptotic functions, cell-cell interactions, DNA replication and in
regulation of transcription of target genes (IV, table 1).
We also studied whether there exist any similarities in host cell gene
regulation during infection of different enteroviruses. For this purpose, HeLa
cells were infected with CBV4 or PV1 for 7 h and the host cell gene
alterations were studied with cDNA arrays containing 588 genes. Some of the
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altered genes found in our study are discussed below in more detail (IV, Fig.
2, Table 1, Fig. 3).
3.1 The upregulation of immediate early genes
At 10 h p.i., over 2-fold expression of several IE genes, including Fos-related
antigen (fra-1), c-jun, and early-growth response protein 1 (egr-1), was
observed in EV1-infected cells (IV, table 1, Fig. 2B). Both Fra-1 and Egr-1
were also upregulated, but less than 2-fold, at 6 h p.i (IV, Fig. 2C). Fra-1 can
heterodimerise with c-jun to form stable AP-1 complexes (Cohen et al., 1989)
that further regulate the transcription of target genes, involved in wide range
of cellular processes. Egr-1 regulates the genes involved in cell growth,
immune response and apoptosis by transactivation of the p53 gene (Thiel and
Cibelli, 2002). Therefore, it is the common link between the diverse pathways
that cause tissue injury (Yan et al., 2000). In addition, upregulation (2.5-fold)
of a gene encoding a transforming growth factor-β-inducible early growth
response protein (TIEG), was detected using another cDNA array with
additional 1176 genes (our unpublished data). TIEG can induce apoptosis and
regulate cell proliferation (Tachibana et al., 1997). Upregulation of IE genes
c-jun, c-myc and pim-1 (IV, Fig. 3) and TIEG (Johannes et al., 1999) was also
observed during PV1 infection in HeLa cells. Accordingly, activation of IE
gene expression has been detected during CBV3 infection (McManus et al.,
2002). Viruses belonging to other families can also regulate the expression of
IE genes, suggesting that these genes are mainly involved in general rather
than specific events in host cells during viral infections (Jenner and Young,
2005).
The increased expression of IE genes c-fos, c-jun and junB during EV1
infection has been shown to occur via MAPKs pathways (Huttunen et al.,
1998). Additional studies are required to specify which MAPKs could activate
the overexpression of fra-1, egr-1 and TIEG in EV1 infection. The gene
encoding MAPK-activated protein kinase 3 (MAPKAPK3), which is an
integrative element of MAPKs signalling in both mitogen and stress
responses, was upregulated in both PV and CBV4 -infected HeLa cells (IV,
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Fig. 3). The enhanced expression of the MAPKs may play a role in regulation
of apoptotic events in the host cell during enterovirus infection, as shown
previously for CBV3 (Huber, 1999).
3.2 The upregulation of IRES-containing cellular genes
Based on metabolic labelling of host cell and viral proteins during EV1
infection, the virus was able to cause a partial inhibition of host cell protein
synthesis (shut-off) in HOS-pα2AW cells in the presence of visible CPE (IV,
Fig. 1B). In contrast, both PV1 and CBV4 induced more complete shut-off
effect in HeLa cells. The results implicate that control of host cell protein
synthesis varies between closely related viruses and may also vary depending
on the cell type.
Those cellular genes, which contain an IRES element, can be efficiently
translated in the presence of enterovirus-induced shut-off (Hellen and Sarnow,
2001). In the presence of a complete shut-off effect in PV1-infected cells, the
upregulation of pim-1 and c-myc mRNAs was detected here (IV) similiar to
earlier findings (Johannes et al., 1999). Somewhat surprisingly, the c-myc
gene was the only currently known IRES-containing gene, which became
elevated during EV1 infection. On the other hand, also those host cell genes,
which lack an IRES element can be translated in EV1-infected cells because
the virus does not cause a complete inhibition of protein synthesis.
The IRES-containing mRNAs encode proteins that are essential for cell
survival during a variety of cell stress situations (Hellen and Sarnow, 2001).
Because the c-myc gene product is a transcription factor that can control cell
vitality and induce apoptosis (Dang, 1999), the overexpression of c-myc gene
during enterovirus infection could, for example, present such a host stress
response to infection.
3.3 Other upregulated genes
During EV1 infection, many genes related to cell survival and apoptosis
were upregulated. Among them were the apoptotic IE genes c-myc, egr-1 and
TIEG mentioned above, and a gene coding for an anti-apoptotic myeloid
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leukaemia cell differentiation protein (MCL-1), which is degraded, for
example, in adenovirus-induced apoptosis (Cucona t i  et al., 2003).
Interestingly, a recent cDNA array comparison of 77 different host-pathogen
interactions revealed that overexpression of MCL-1 is highly common in
pathogen-activated cells (Jenner and Young, 2005). MCL-1  is regulated
through ERK-1-mediated signalling pathway (Michels et al., 2005), which is
activated at 5 h after EV1 infection (Huttunen et al., 1998). However, further
studies on these genes are required to solve whether EV1 regulates the
balance between antiapoptotic and apoptotic pathways like PVs (Belov et al.,
2003).
The expression of several transcriptional and translational regulators,
e.g. nuclease sensitive element binding protein 1 (NSEP1; YB-1) and
ribosomal protein L6 gene, coding for a protein component of ribosomal 60S
subunit (Zaman, 1993), were increased in EV1 infection. NSEP1 regulates
DNA-dependent transcription, modulates viral gene expression of HIV
(Kohno et al., 2003), and facilitates adenovirus replication (Holm et al.,
2002). Here, the overexpression of these genes may enhance the transcription
and translation of cellular genes important for EV1 infection and/or for host
cell defence mechansims.
Cell stress -related genes, such as growth arrest and DNA-damage-inducible
protein (GADD45) and a cAMP-dependent transcription factor 4 (ATF4) were
highly overexpressed in EV1 infected cells at 10 h p.i. The activation of
Gadd45 gene is also observed in apoptosis (Sheikh et al., 2000), in DNA
repair (Smith and Seo, 2002) and in several virus infections (Jenner and
Young, 2005). Genes of the ATF family have also been observed to be
upregulated during CBV3 (Taylor et al., 2000) (McManus et al., 2002) and
PV1 infections (Johannes et al., 1999). Thus, the universal laws of stress
responses may also apply to viruses.
A gene encoding the monocyte chemotactic protein 1 precursor (MCP-1), a
chemokine, was 2.9-fold upregulated at 10 h of EV1 infection. MCP-1 has
also been found to be upregulated following picornavirus (CVB3 and CVB4)
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infection in human astrocytes (Kwon et al., 2004), after influenza A virus
infection (Sprenger et al., 1996) and in HIV-1 infection in mice (Potash et al.,
2005). Therefore, the induction of MCP-1 most probably represents a general
immune reaction against pathogens.
In summary, the overexpression of IE genes, stress response genes and genes
related to cell survival and apoptosis appears to be related to viral infections
in general. In contrast, upregulation of the cellular IRES-containing genes in
the presence of cellular protein synthesis shut-off may represent a specific
host cell response to those viruses, which interfere with cap-dependent
translation. In future studies, it would be interesting to find out whether the
induction of genes coding for certain kinases (e.g. CDC-like kinase 1, a
threonine-tyrosine kinase; IV, Table 1) could be particularly important in the
conversation between EV1 and the host cell. Moreover, further studies with
other techniques such as Western blotting are required to confirm whether the
upregulated genes are translated into functional proteins in the infected cells.
So far, the discussion about the functions of (up)regulated genes and their
products in EV1 infection remains rather speculative. Nevertheless, the study
provides significant data for further investigations of EV1-mediated signalling
events and viral pathogenesis.
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CONCLUSIONS
The articles I-IV included in the thesis illuminate cellular interactions of
echovirus 1, a human pathogen. The basic mechanisms of virus - host cell
interactions share common properties amongst all viral pathogens. However,
the detailed contacts between viruses and host cells can vary within the
closely related viruses and even be serotype-specific, as illustrated here with
EV1.
The cryo-EM reconstruction of EV1 in complex with the α2I domain of its
receptor, α2β1 integrin, provides the first structure of integrin bound to
picornavirus. The integrin binding site in EV1 canyon is closely similar to the
binding sites of ICAM-1 in major group HRVs and of PVR in PVs. However,
the proposed mechanism by which canyon-binding receptors initiate the
instant uncoating of the virus (Rossmann et al., 2002) may not to be valid for
EV1. Instead, the integrin-interaction may inhibit the instant disassembly of
EV1 particles to ensure that the release of viral genome takes place after
internalization of the virus into the cells.
The significant differences between EV1 and collagen in their binding to
α2β1 integrin strengthen the view that viruses have, during evolution,
maximised their capability to compete with physiological ligands. To ensure
the efficient attachment to the cell surface, EV1 has taken benefit of the
higher affinity for the receptor compared to the natural ligand and of the
ability of the virus to bind several integrin molecules simultaneously.
Moreover, EV1 has exploited the signalling properties of the integrins to
facilitate its internalization and replication. On the other hand, the signalling
triggered by the receptor after interactions with the virus can also prepare the
host cell for the viral invasion (Pelkmans and Helenius, 2003).
To cross the membrane barrier as well as to evade the host immune system, it
is advantageous for viruses to utilize the endocytic machinery. Unlike many
other picornaviruses, EV1 does not utilize clathrin-mediated uptake. Instead,
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it can be internalised into caveosomes through cell surface caveolae and/or
through another, still undefined, internalization route that may involve non-
caveolar lipid rafts. Determination of particular cellular components and
molecular mechanisms involved in EV1 uptake into caveosomes will be of
great importance in the future studies.
EV1 may remain in caveosomes until the uncoating and replication of the
virus take place. Thus, it differs from other known caveosomal ligands, which
traffic from caveosomes to the ER or to the Golgi (Pelkmans et al., 2001; Le
and Nabi, 2003). Therefore, it will be relevant to investigate the specific
mechanisms of viral uncoating and viral RNA release in/from caveosomes. In
addition, EV1 provides an excellent instrument for solving the missing links
of the caveosomal pathway because the viral genome is easy to manipulate
and, as shown here, the direct fluorescent labelling of EV1 capsid proteins
provides a useful tool to follow the dynamic process of virus uptake into live
cells. Real-time live microscopy of fluorescently labelled virus particles could
also be applied to the elucidation of currently unknown endocytic routes of
other picornaviruses.
EV1, like all viruses, survives during the interaction with host cells by
controlling the cell’s function by multiple mechanisms, including the
regulation of host cell protein translation and gene expression. cDNA arrays
are advantageous for identifying universal patterns in cellular gene expression
during virus infections. In the future, cDNA arrays may also have a
considerable impact on the diagnosis and therapy of infectious diseases
(Manger and Relman, 2000). In spite of significant benefits of cDNA array
techniques, additional investigations are required to resolve which of those
host genes shown to be regulated during EV1 infection are involved in EV1-
host cell interactions, in general mechanisms of viral pathogenesis and in host
cell defence.
Viruses have evolved to utilize the existing cellular molecules and functions
for infection. Therefore, the studies on virus infections have provided
solutions to several phenomena in molecular and cell biology. The findings
reported here demonstrate that EV1 can serve as such a "model" virus to
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illuminate virus - host cell interactions. Hopefully, the findings presented in
this thesis will promote studies of virus-receptor interactions in general as
well as more detailed investigations of currently poorly known cellular
pathways.
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